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ABSTRACT
This dissertation is a compilation of three studies that were conducted to better 1) Further
validate a thoroughly tested Framingham Risk Score (FRS) on a unique cohort with
comprehensive measures available, 2) Update and improve the predictability of the FRS
through the addition of cardiorespiratory fitness (CRF) while resolving limitations in
previous studies, and 3) Assess the predictability of non-exercise estimated CRF (e-CRF)
and FRS on CHD. A manuscript was generated for each study utilizing data from the
Aerobics Center Longitudinal Study.
To validate the FRS, a multivariable Cox Proportional Hazard Model was used to
determine the association between FRS component and CHD. The Area Under the Curve
(c-statistic) from the receiver operating characteristic (ROC) curve was used to determine
predictability of the FRS model on ACLS. The FRS’ components were significantly
associated with CHD and the c-statistic was statistically significant.
The second study’s goal was to update the FRS by adding CRF. This study
included 29,854 men from ACLS that completed a baseline examination from 19792002. FRS was defined as a composite score and modeled as a continuous and categorical
variable. CRF was defined as a continuous variable through maximally achieved
metabolic equivalent of task (METs) and categorical: low, moderate, or high CRF.
Multivariable survival analysis showed a significant association between CRF, FRS and
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CHD. Although the second study found there was a significant relationship with CRF,
FRS, and CHD, traditionally measured CRF is not a clinically viable tool.
The third study aim was to use a non-exercise estimated CRF (e-CRF) to
determine the relationship between e-CRF, FRS, and CHD. Estimated CRF was defined
through a 5-item questionnaire and the same data from study #2 was utilized for the
multivariable Cox Proportional Hazard modeling. The relationship between e-CRF and
CHD was investigated in subset populations based on age, smoking, hypertension, and
diabetes diagnosis. Our study found that among men with ‘moderate or high’ risk for
CHD, men with moderate or high fitness had a decreased risk for CHD compared to men
with low fitness.
CHD is one of the leading causes of death in the U.S. and early establishment of
CHD risk is important for primary and secondary prevention. The series of papers
presented in this dissertation provide the evidence needed to begin establishing a more
comprehensive and clinically feasible risk prediction tool. Clinicians may want to
consider capturing their patients’ medical history, CHD risk factors, and their e-CRF so
they can take advantage of CRF’s improved prediction of CHD. This comprehensive
approach can help physicians predict adverse events for their patients while also
counseling them on how to improve their overall health through improvement of CRF.
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CHAPTER I
INTRODUCTION

Statement of the Problem
Cardiovascular diseases (CVDs), including coronary heart disease (CHD) and stroke,
represent the leading cause of death in the United States. 1 CVDs account for
approximately 17% of the overall national health care expenditures. 1-3 The American
Heart Association (AHA) stated in 2004 that their goal for 2010 is to “…reduce coronary
heart disease (CHD), stroke, and risk by 25%” utilizing the following indicators: reduce
death rate due to CHD and stroke 25%, reduce prevalence of associated risk factors
(smoking, physical inactivity, high cholesterol, and high blood pressure), and eliminate
the progression of obesity and diabetes. 4 The AHA recognized the need to expand their
2010 goals for their 2020 proposal. AHA decided to broaden its scope beyond CHD to
include all of cardiovascular disease (CVD) mortality and CVD health. The 2020 goal of
the American Heart Association is to reduce the deaths caused by CVD and stroke by
20% 5 and to improve the cardiovascular health of Americans by 20%.
The AHA estimates that more than one in three adults have one or more types of
CVD with approximately 50% of this population over the age of 59 years. 5 Within the 45
million adults reporting having a functional disability, heart disease is among the 15
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leading conditions that caused those disabilities. Disability was defined as difficulty with
daily activities and limitation in ability to do work around the house or on the job. 5
CHD is the accrual of plaque in the arteries of the heart 6 that supply the heart
with blood to maintain normal cardiac function. The accumulation of plaque narrows the
heart’s arteries forcing the heart muscle to work harder. The formation of CHD depends
on the extent of plaque build-up, reduced blood flow, and damage caused to the heart
muscle. The deprivation of oxygen to the heart muscle may cause dead muscle cells or
scar tissue to form, decreasing the pump efficiency of the heart and often the
accumulation of blood on the right side. Another main cause of CHD is the deposition of
fat beneath the endothelium reducing the elasticity of arteries. Decreased elasticity,
coupled with high blood pressure, could lead to the artery hemorrhaging, also called an
aneurysm. CHD has substantially decreased worldwide in the past 30 years 7,8 primarily
due to the improvements of modifiable lifestyle characteristics. 9,10 The modifiable
lifestyle characteristics include smoking, high blood pressure, and high cholesterol.
An American Cancer Society Cancer Prevention Study compared two different
groups derived at different time points with a 20-year gap between them: group one was
surveyed between 1959-1965 while group two was surveyed between 1982-1988. 11 The
survey of these volunteers in both groups showed that there was a noticeable decline in
deaths related to CHD between the two sampling periods. Although both lifelong
nonsmokers and smokers at enrollment experienced a decline in CHD mortality, the
smokers at enrollment still had a higher mortality ratio. 11 These results show that
although smoking cessation decreases an individual’s risk for mortality compared to
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current smokers, past smokers are still at a higher risk of CHD mortality than lifelong
nonsmokers.
High blood pressure can subject an individual’s arteries to increased force that
creates microscopic tears in the walls that may develop in to scar tissue. 6 This scar tissue
creates a lattice for plaque to accumulate within the artery and may eventually lead to a
partial or full blockage. 6 Cholesterol is a substance that contributes to plaque formation.
12

High cholesterol coupled with high blood pressure and scar tissue formation within

arteries may increase an individual’s risk for CHD. 6,13 Most deaths related to high
blood pressure or high cholesterol are attributed to CHD. 13 It is important to note that the
decrease of CHD mortality in recent years can be attributed to the improvement of blood
pressure and cholesterol management. 14
The body breaks down the food we consume into sugars, which it utilizes as an
energy source. 15 The pancreas produces insulin that enables the cells within the body to
utilize these sugars. 6 Diabetes is diagnosed when the body cannot adequately utilize
these synthesized sugars. 16 Diabetes can cause impairment in the cardiac muscle that
may lead to cardiomyopathy, congestive heart failure, or ischemic heart disease and can
increase the 5-year mortality rate after a myocardial infarction. 16,17 Research shows that
individuals with diabetes and hypertension have a higher incidence of heart disease
compared to people with diabetes or hypertension alone. 18,19 16
Investigators from across the world have taken these and other covariates into
consideration as they have developed risk factor scores to help model and predict an
individual’s risk for CHD in a given time period. The Prospective Cardiovascular
Münster Study (PROCAM) cohort of middle-aged men was utilized to develop a risk
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factor score encompassing age, low density lipoprotein, high density lipoprotein,
triglycerides, smoking status, diabetes diagnosis, family history of myocardial infarction,
and systolic blood pressure. 20 The Second Joint Task Force instigated the development
of a risk score that was based on European cohorts in 12 different countries. 21 The result
was a sex- and age-stratified risk chart that assessed the individual’s smoking history and
cholesterol profile. This risk chart is aimed to estimate the total risk of CVD rather than
just CHD. 21
The Framingham Heart Study developed a risk score aimed at simplifying the
dynamic and potentially convoluted task of estimating a person’s CHD risk. 22 The
Framingham Risk Score (FRS) utilized the Framingham Heart Study cohort that dates
back to 1948. 23 The original risk score was derived more than forty years ago and, when
updated in 1991, the risk factors considered remained the same: age, systolic blood
pressure, diastolic blood pressure, cholesterol (total cholesterol and high density
lipoproteins), smoking status, diagnosis of diabetes, and electrocardiogram to determine
CHD risk. 22 The result from the FRS regression model was translated into a worksheet
that clinicians can employ for the approximation of the five and ten year risk for CHD. 22
In a recent publication from Sposito et al, 48% of surveyed physicians across the globe
self-reported utilizing the FRS more often than other scores, 24 which was higher than any
other risk score.
An initial limitation of the FRS was the homogeneous demographic that
comprised the Framingham Heart Study. The population recruited for the Framingham
Heart Study is derived from a suburb west of Boston and is comprised primarily of Non-
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Hispanic White men and women. 25 However, since its origination, FRS or similar scores
have been applied to various racial and ethnic populations.
The Honolulu Heart Study was initiated in 1965with the overall concept of
standardizing cardiovascular examination. 26 The cohort was comprised of Japanese men
born between 1900 and 1919 and updated their World War II Selective Service Files; the
final population with a baseline examination was approximately 8,000 individuals. 26 The
majority of this population consisted of first generation immigrants, 50% never attended
high school and only 15% had any technical or university training. 26
Validation of the FRS also occurred in the Physician’s Health Study. Male
physicians in the United States between 40-84 years of age (n=22,071) were randomized
in a double-blinded, placebo-controlled study. 27 Coronary risk factors were collected
through questionnaires prior to randomization and surveys were mailed to the participants
every 6 months. Individuals would self-report nonfatal CHD incidence, and the nonresponders were followed up with a telephone-based survey. 27 Stampfer et al also found
similar effects of the FRS covariates , with the exception of smoking. The Physician’s
Health Study also reported the significant joint effect HDL and total cholesterol has on
CHD’s relative risk. 27,28
There are various risk factors that have a significant relationship with CHD and
other cardiovascular events. However, it is not enough for these risk factors to have
independent predictive power, the risk factor has to improve the predictability traits that
the traditional risk score, FRS, encompasses. Pischon et al investigated the predictive
power of C-reactive protein (CRP) and the feasibility to substitute this for low-density
lipoprotein cholesterol measure 29. CRP was measured through highly sensitive assays
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and then applied to the FRS. 29 Cox regression indicated that the FRS plus CRP was a
significant prediction model for myocardial infarction and stroke; although the inclusion
of CRP did not improve the predictive accuracy of the original FRS. 29
Instead of attempting to modify the FRS with biological factors, Gallo et al
evaluated augmentation of the FRS with social factors that may increase the risk of CHD.
30

Gallo et al. explored the effect involuntary job loss after the age of 50 years may have

on 10-year risk on myocardial infarction and stroke. They used a Cox regression model to
analyze the first ten years of data in the US Health and Retirement Survey with the
outcome as self-reported myocardial infarction or stroke. Job loss was the main
independent variable and was treated as a time dependent variable. 30 Gallo and his
associates found that individuals who lost their job involuntarily had a 2.48 times higher
risk (95% CI 1.49-4.14) for myocardial infarction and a 2.43 higher risk of stroke
compared to individuals who did not experience involuntary job loss. 30 Like many
studies that attempted to improve or modify the FRS, Gallo et al did not perform
goodness-of-fit tests to determine if this model was truly a better predictor of 10-year
cardiovascular disease risk than the original FRS.
During Wilson et al’s augmentation of the 1991 FRS model, the analysis tested
the addition of other risk factors 25 and considered the inclusion of physical activity or
CRF. Unfortunately, the Framingham Heart Study did not capture this information at the
baseline examination prohibiting its inclusion in the model. 25
Physical activity could improve an individual’s blood pressure, cholesterol levels,
and glucose tolerance through various mechanisms. 31 Regular physical activity promotes
higher levels of high-density lipoproteins that help countervail the effect of low-density
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lipoprotein cholesterol, improve the efficiency of pumping in the heart, and retard
clotting formation within arteries. 6,32 From a research standpoint, measuring physical
activity is not entirely standardized. Physical activity has been categorized differently
across studies, which has produced variable results, thus making comparability to
previous findings difficult. 33 In addition to this, the primary components that calculate
the volume of physical activity (duration, intensity, and frequency) performed cannot be
captured accurately. 33 Cardiorespiratory fitness (CRF) resolves the limitation of physical
activity measures not being able to capture energy expenditure consistently.
Usual physical activity habits are the primary determinant of fitness 34 in addition
to CRF’s genetic component. 35-37 Cardiorespiratory fitness (CRF) is defined as the
ability of the circulatory system to supply and utilize oxygen during sustained physical
activity. 38 Cardiorespiratory fitness is typically measured in epidemiological studies
through maximal or submaximal exercise tests to measure exercise capacity. 39 CRF has
been shown to have a significant protective relationship for various outcomes that range
from a diabetes diagnosis, 34,40 cancer morbidity, 41 obesity, CHD diagnosis, 42 all-cause
mortality, 43 diabetes mortality, 40,44 and CHD mortality. 45,46
A large prospective cohort focused on determining the independent and joint
associations CRF and obesity may have on the incidence of type 2 diabetes in American
women. 34. More than 140 women developed diabetes in a 17-year follow-up period. 34
Age-adjusted incidence rates were calculated for increments of CRF and the results show
that women with a low exercise capacity (<7 METs) had a three times higher risk of
developing type 2 diabetes compared to women with a higher exercise capacity (≥10
METs). 34 When the combined effects of CRF and BMI were analyzed, normal-weight
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(BMI <25 kg/m2) unfit women (lowest CRF tertile) did not present an increased risk for
diabetes incidence while overweight/obese (BMI≥25 kg/m2) unfit women had twice the
risk for diabetes incidence; both groups were compared to the referent group comprised
of normal weight fit women. 34
CRF is also protective against all-cause mortality. More than 13,000 participants
from the Aerobic Center Longitudinal Study (ACLS) were divided into quintiles of
fitness and then analyzed for various joint effects of fitness and various comorbidities on
all-cause mortality. 43 In men with cardiovascular disease, there was a significant
protective linear trend relationship between CRF and all-cause mortality. 43
An early study portrayed the significant effect CRF has on CHD risk factors in
women. 42 Women ages 18-65 years who completed a comprehensive medical exam
between 1971 and 1980 were included in the regression analysis to determine the
relationship between CRF and CHD, a relationship already found to be significant in
men. 47-49 The CHD risk factors employed in the analysis were based on the Framingham
Risk Score. 23 CRF was shown to have significant impact on the CHD risk factors,
including current smoking, total cholesterol, HDL cholesterol, and blood pressure. 42
To better assess the risk factors for CHD mortality and the impact CRF may have,
Lee et al (1999) conducted an analysis to examine the relationship between body
composition, CRF, and CHD mortality. Approximately 22,000 men completed a medical
examination between 1971 and 1989. 46 Body composition of these men was measured
either through hydrostatic weighing, skinfold-thickness measurements, or both; body
composition was defined as a three-level variable: lean (<25th percentile), normal (25th to
<75th percentile), or obese (≥75th percentile). Unfit lean men had a significantly three
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times higher risk for CHD mortality compared to fit lean men46. Although there were
significantly higher risks of CHD mortality across the body composition groups, this
significant relationship was attenuated in fit men. Fit men with a normal body
composition had a 1.43 (95% CI 0.77, 2.67) higher risk of CHD mortality compared to
fit lean men while fit obese men had a 1.35(95% CI 0.66, 2.76) times higher risk
compared to referent group 46 although neither association were statistically significant.
Gupta et al sought to determine CRF’s contribution to traditional CHD risk
factors 50 and utilized the ACLS cohort with data collected from 1970 through 2006. CRF
was defined as quintiles and the results showed that all variables included in the
traditional risk factor score and all quintiles of CRF were significant with CHD mortality.
50

When comparing the traditional versus CRF-augmented model in men, the CRF-

augmented CHD risk factor model correctly reclassified participants with CHD death
based on their 10-year risk. 50 However, a potential limitation of this study was the use of
a very basic model to represent the traditional CHD risk factor model which included
only age, systolic blood pressure, diabetes, total cholesterol, and smoking status. The
FRS includes the covariates mentioned in Gupta et al’s report, adjusts for sex similarly to
Gupta et al, but also includes diastolic blood pressure and high density lipoproteins in
their risk calculation. 22

Purpose and Study Aims
CHD is one of the leading causes of death in the United States. A diagnosis of
CHD can cost an individual tens of thousands of dollars and shorten his or her lifespan.
FRS provides clinicians a tool to accurately predict their patients’ 10-year risk for CHD
that can be used to prevent disease. CRF has been consistently shown to provide a
9

protective effect on CHD as well as other comorbidities associated with CHD. The
purpose of this study is to further validate a thoroughly tested FRS on a unique cohort
with comprehensive measures available; update and improve the predictability of the
FRS through the addition of CRF while resolving limitations in previous studies; and
asses the predictability of non-exercise estimated CRF (e-CRF) and FRS on CHD.

PAPER 1: Framingham Risk Score (FRS) applied to the Aerobic Center
Longitudinal Study (ACLS)
Hypothesis: The Framingham Risk Score will significantly predict CHD events for men
within the ACLS population
PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness
(CRF)
Hypothesis: The CRF variable will improve the Framingham Risk Score predictive
ability of CHD events for men within the ACLS population
PAPER 3: Determine the association between non-exercise estimated CRF (e-CRF)
and CHD. Utilize e-CRF and FRS to predict the risk of CHD.
Hypothesis: Estimated CRF (e-CRF) will be significantly protective against CHD. We
also hypothesized that e-CRF and FRS will have a significant association with CHD.

Study Outline
Chapter I of this dissertation has served as an introduction to the problems
associated with CHD, the purpose of this research, and the study’s hypothesizes. Chapter
10

II is a review of the relevant literature. This review provides detailed insight on CHD and
how CHD prevalence and CHD mortality incidence has changed over time. This chapter
continues to discuss the clinical tools generated by researchers and implemented by
physicians to help detect this problem in hopes of preventing CHD. Chapter II focuses on
the FRS and its ability to predict a 10-year CHD risk. The chapter also points out the
limitations of FRS and proceeds to state how this publication will correct for these
limitations. Chapter III states the methodology employed to test the hypothesis in each of
the three manuscripts. Chapter IV represents Paper 1 ‘Framingham Risk Score applied to
the Aerobic Center Longitudinal Study (ACLS)’ including background, results, and
discussion in manuscript layout. Chapter V focuses on Paper 2 ‘Augment the
Framingham Risk Score (FRS) applied to the Aerobic Center Longitudinal Study (ACLS)
with the addition of Cardiorespiratory Fitness (CRF)’ and reporting the results of the
analysis aimed at augmenting FRS; this chapter is formatted similar to Chapter IV. The
subsequent chapter, Chapter VI, captures the results from Paper 3 ‘Determine the
association between estimated CRF (e-CRF) and CHD. Utilize e-CRF and FRS to predict
the risk of CHD’. Chapter VII concludes the dissertation through the summation of each
of the three presented papers and their specific hypotheses. Chapter VII also includes
how the conclusions from each paper relate to one another, the strengths and limitations
to the research, possible directions for future research, overall conclusions, and the
lessons learned throughout the dissertation process.
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CHAPTER II
LITERATURE REVIEW
The following literature review will reiterate findings from several studies on the severity
of coronary heart disease, encompassing characteristics of the Framingham Risk Score,
the positive health effects of cardiorespiratory fitness, Framingham Risk Score’s 10-year
risk predictability of CHD events, and the potential augmentation of this risk score with
the addition of cardiorespiratory fitness.

Overview of Coronary Heart Disease
Brief History
The American Heart Association (AHA) stated in 2004 that their goal for 2010 is
to “…reduce coronary heart disease (CHD), stroke, and risk by 25%” utilizing the
following indicators: reduce death rate due to CHD and stroke 25%, reduce prevalence of
associated risk factors ( smoking, physical inactivity, high cholesterol, and high blood
pressure), and eliminate the progression of obesity and diabetes. 4
Lloyd-Jones reported the progress of the reduction of CHD, stroke, high blood
pressure, and high cholesterol depicted in Figure 2.1. 4 The achievement of these goals is
partially attributed to the work practitioners and scientists conducted to improve medical
prevention and treatment of heart disease and public health’s initiative to eliminate
smoking and increase individuals’ physical activity while controlling their blood pressure
and cholesterol. 4
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Figure 2.1. Trajectory of mortality rates from coronary heart disease (CHD)
and stroke, rate of uncontrolled high blood pressure, and prevalence of high
blood cholesterol from 2004 to 2008 (Lloyd-Jones, Adams et al. 2009)

Previous literature has shown an inverse relationship between physical activity
and physical fitness and the incidence of CHD. 48,51-53 Clinicians seldom consider
cardiorespiratory fitness when evaluating their patient’s risk for CHD. 25,51 One theory
behind the lack of consideration CRF receives in clinical assessment of CHD is a poorly
established association between CRF and CHD. 51
A meta-analysis determined that individuals who were moderately physically
active had a lower risk of CHD than sedentary individuals. 54 Following this theory, a
more recent meta-analysis of 33 eligible studies depicted an association between CRF
and CHD. 51 The individuals with a low CRF had an RR for all-cause mortality of 1.40
(95% CI 1.23-1.48, p-value<0.001) and for CHD/CVD events of 1.47 (95%CI 1.35-1.61,
p=value<0.001) while adjusting for heterogeneity of study design. 51
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The meta-analysis performed by Kodama, 2009 showed a dose-response
relationship between a 1-MET increase of MAC (maximum aerobic capacity) and a 13%
and 15% decrements in risk of all-cause mortality and CHD/CVD, respectively. 51 In
categorical analysis, individuals with a low CRF had significant higher risk for
CHD/CVD compared to individuals with intermediate or high CRF. 51

Current Public Health Undertakings
The AHA recognized the need to expand their 2010 goals for their 2020 proposal.
AHA decided to broaden its scope beyond CHD to include all of cardiovascular disease
(CVD) mortality and CVD health. To evaluate CHD and CVD health, a comprehensive
metric was developed. 4 This metric recognized physical activity as a significant factor in
CVD and CHD, as well as smoking status, body mass index, diet score, cholesterol,
blood pressure, and fasting plasma glucose. The 2020 goal of the American Heart
Association is to reduce the deaths caused by CVD and stroke by 20% 5 and to improve
the cardiovascular health of Americans by 20%.

Health Care Costs
The US continues to spend more money per capita than any other country on
health care. 55 CHD and CVD remain among the leading causes of death in the United
States and comprise approximately 17% of the overall national health care expenditures.
1-3

In the past ten years, the medical costs of CVD have grown at an average of 6% per

year. 56 However the US also has observed a longer life expectancy 57 and as the US
population ages, the cost of CVD is expected to increase significantly.
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Heidenreich et al produced a detailed methodology to project and predict the
future costs of CVD and related diseases from 2010 to 2030 (Table 1). 55 The CVD
conditions that Heidenreich et al included in their analysis were hypertension, CHD, heart
failure, and stroke. 55

Table 2.1. Projections of Crude CVD Prevalence (%), 2010-2030
in the United Stated (Heidenreich, Trogdon et al. 2011)

The primary data source utilized by Heidenreich and his colleagues was the 20012005 Medical Expenditure Panel Survey. 55 Cost associated to each CVD condition was
calculated as the difference between predicted expenditures for an individual with the
condition compared to an individual without the condition. 55 Total direct (Table 2.2) and
indirect (Table 2.3) medical costs of CVD were estimated by multiplying the per person
cost of each CVD condition by the projected number of individuals with the condition. 55
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Table 2.2. Projected Direct
(Medical) Costs of CVD,
2010-2030 (in Billions 2008$)
in the United Stated

Table 2.3. Projected Indirect (Lost
Productivity) Costs of CVD,
2010-2030 (in Billions 2008$) in
the United Stated (Heidenreich,

(Heidenreich, Trogdon et al. 2011)

Trogdon et al. 2011)

The authors also calculated indirect costs based on lost productivity for two
reasons: CVD related morbidity, and premature mortality. 55 This projection determined
that approximately 40% of the US population will have some form of CVD by the year
2030. 55 This increase in CVD prevalence will result in the total direct medical costs
tripling and indirect costs increasing from $171.1 billion to $275.8. 55
The AHA estimates that more than one in three adults have one or more types of
CVD with approximately 50% of this population over the age of 59 (Figure 2.2)5. Within
the 45 million adults reporting having a functional disability, heart disease is among the
15 leading conditions that caused those disabilities. Disability was defined as difficulty
with daily activities and limitation in ability to do work around the house or on the job. 5
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Figure 2.2. Incidence of cardiovascular diseases’ by age and sex
(Framingham Heart Study, 1980-2003). Coronary heart disease, heart failure,
stroke, or intermittent claudication. Does not include hypertension alone.
(American Heart Association 2013)

Quality of Care
Institute of Medicine defines quality of care as “the degree to which health
services for individuals and populations increase the likelihood of desired health
outcomes and are consistent with current professional knowledge.” 58 There are six
specific domains that quality of care envelops: safety, effectiveness, patient-centered,
timely, efficient, and equitable.
Effective care involves providing scientifically based services for those
individuals that could benefit while refraining from causing harm to those who will not
benefit. 5 Medicare data from July 2005- June 2008 was employed to determine the 30day mortality and 30-day readmission after hospitalization for heart failure and acute
myocardial infarction. 59,60 The results showed the median risk-standardized mortality
rate was 11.1% for heart failure and 16.6% for acute myocardial infarction. The median
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risk-standardized readmission rate was 24.4% and 19.9% for heart failure and acute
myocardial infarction, respectively. 59,60
Timely care is an integral factor of any CHD service and is an important service
for health care and other industries to focus on. A study titled Can Rapid Risk
Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early
Implementation of the ACC/AHA Guidelines (CRUSADE) depicted that for non-STelevation myocardial infarction (NSTEMI) patients, the median delay from symptom
onset to hospital presentation was 2.6 hours. This was significantly related to withinhospital mortality and did not change from 2001-2006. 61

Biological Mechanisms
CHD is the accrual of plaque in the arteries of the heart 6 that supply the heart
with blood to maintain normal function. The accumulation of plaque narrows the heart’s
arteries forcing the heart muscle to work harder. The form of CHD depends on the extent
of plaque build-up, reduce blood flow, and damage caused to the heart muscle. The
deprivation of oxygen to the heart muscle may create dead muscle cells or scar tissue to
form, decreasing the pump efficiency of the heart and often the accumulation of blood on
the right side. Another main cause of CHD is the depositing of fat beneath the
endothelium reducing the elasticity of arteries. Decreased elasticity coupled with high
blood pressure could lead to the artery hemorrhaging, also called an aneurysm.
Lipoprotein lipase (LPL) has been linked to the risk of CHD. 62 Many studies
have documented strong inverse relationship between LPL activity and CHD 62. Previous
literature has reported even slight reductions in LPL activity have increased the relative
risk for mortality or CHD five times higher compared to healthy controls. 63 LPL is an
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enzyme essential for lipolysis of triglycerides and can have various effects on
metabolism. 64,65 Jensen et al investigated that overexpressing LPL in the muscle fat of
mice would prevent feeding-induced obesity by diverting the lipoprotein-derived
triglyceride fatty acids away from being stored by the body and would then, in turn, be
oxidized by the muscle. 65 Mice were examined before and after the high fat feeding
intervention. At the conclusion of the 13 week high fat feeding, the mice that were
targeted for overexpression of LPL in skeletal muscle had lower diet-induced lipid
accumulation. 65
A more recent rat study focused on three long-standing biological mechanisms
associated with CHD: physical activity, insulin sensitivity, and fat storage. 66 Booth et al
employed a wheel-lock model on the group of rodents. The wheel-lock model was to
simulate the physiological changes that take place when there are changes from high
physical activity levels to a more sedentary lifestyle. 66 Four week old rats were allowed
access to running wheels for 3 weeks where they were running an average of ~5km/day
by the third week. 67 The rats were then divided in to four groups: sedentary (rats who
never run), and rats with their wheels locked for 5, 29, or 53 consistent hours. The group
of rats with a wheel-lock for 5 hours was classified as the referent or healthy group. The
sedentary group and the group that experienced wheel lock for 53 hours showed a
significant reduction in insulin sensitivity compared to the referent group. Booth et al’s
findings are concurrent with previous human studies that depicted a loss of whole-body
sensitivity at 38 and 60 hours after termination of endurance training. 68,69 Figure 2.3
shows decreased insulin sensitivity in muscles diverts energy away from muscle
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glycogen synthesis 70 and may cause lower mitochondrial density in skeletal muscle
resulting in metabolic dysfunction 67.

Figure 2.3. A hypothetical sequence to type 2 diabetes is shown (see
text for description) (Booth, Laye et al. 2008)

Patient History: Overview
CHD has substantially decreased worldwide in the past 30 years 7,8 primarily due
to the improvements of modifiable lifestyle characteristics. 9,10 The modifiable lifestyle
characteristics include smoking, high blood pressure, high cholesterol, physical
inactivity, cardiorespiratory fitness, body mass index, and diabetes mellitus.

Patient History: Smoking
Doyle et al published one of the first studies examining the association between
smoking and CHD. 71 Doyle published findings derived from two prospective studies:
The Framingham Study and the Albany, New York Civil Servant study and had a
combined study population of over 1,800 men without CHD. 71 The study concluded that
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while problems with blood pressure and cholesterol were absent, the participants that
reported being a smoker had an increased risk of CHD mortality compared to nonsmokers. 71
An American Cancer Society Cancer Prevention Study compared two different
groups derived at different time points with a 20 year gap between them: group one was
surveyed between 1959-1965 while group two was surveyed between 1982-1988. 11 The
survey of these volunteers in both groups showed that there was a noticeable decline in
deaths related to CHD between the two sampling periods. Although both lifelong
nonsmokers and smokers at enrollment experienced a decline in CHD mortality, the
smokers at enrollment still had a higher mortality risk. 11
This decreasing prevalence of smoking continues. A recent 2012 article published
in the American Journal of Public Health reported similar results from the Minnesota
Health Study72. The Minnesota Health Study is a population-based cross-sectional study
to examine the trends of risk factors associated with cardiovascular disease. The ageadjusted prevalence of smoking significantly decreased more than 15% in both men and
women (p-value<0.001) .72 National studies present similar results. 73

Patient History: High Blood Pressure
Elevated blood pressure creates more strain for the heart which can lead to
thickening and rigidity of the muscle 6. This stiffness significantly increases an
individual’s risk for a CHD. High blood pressure can also subject an individual’s arteries
to increase force that creates microscopic tears in the walls that may develop in to scar
tissue. 6 This scar tissue creates a lattice for plaque to accumulate within the artery and
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may eventually lead to a partial or full blockage. 6 Most deaths related to high blood
pressure are attributed to CHD .13
An important cause of the decrease of CHD mortality in recent years is
improvement of blood pressure management. 14 This also is supported by a recent
publication on a population based Canadian study. They reported a 1.4 mmHg decrease
in mean systolic blood pressure from 1994 to 2005 that could be associated with a 20%
reduction in CHD deaths. 14 9 Myocardial ischemia is common in patients with
hypertension. 16,74,75 In early patients with hypertension, decreased ventricular relaxation
during diastole impairs the heart’s ability to fill 76 while the more severe hypertensive
cases experience myocardial wall thickness. 16 A continued decline in ventricular
function could lead to heart failure. Reports from the Framingham study showed that
hypertension was the primary cause of congestive heart failure for 35% of cases. 77

Patient History: High Cholesterol
Cholesterol is a substance that contributes to plaque formation .12 High cholesterol
coupled with high blood pressure and scar tissue formation within arteries may increase
an individual’s risk for CHD. 6,13
The aforementioned Canadian study also reported the prevention of over 1,700
CHD deaths due to a 23% reduction in mean cholesterol level. 14 Data from the National
Health and Nutrition Examination Study depicted a decrease in the mean of total
cholesterol in the United States between two survey time points: 1988-1994 and 19992000. 78 Hypercholesterolemia is an asymptomatic disease and regular blood screenings
are important for detection. 6 Ford et al reported that nearly 60% of 20-44 year olds have
ever had their cholesterol checked while 85% of 45-64 year olds have completed
22

screening. 78 Ford also reports that those individuals reporting being diagnosed with
hypercholesterolemia, only a total of 24% were regularly treating their high cholesterol
(≥6.2 mmol/L), with men reporting a high prevalence of treatment compared to women.
78

Patient History: Diabetes mellitus
When food is consumed, it is usually broken down in to sugar for the body’s
energy source. The pancreas produces insulin that enables the cells within the body to
utilize these sugars. 6 Diabetes is diagnosed when the body cannot adequately utilize
these synthesized sugars because of 1) reduced insulin production within the pancreas, or
2) the body becomes insulin resistant. 6 Research shows that individuals with diabetes
and hypertension have a higher incidence of heart disease compared to those with
diabetes or hypertension alone. 16 Diabetes can cause impairment in the cardiac muscle
that may lead to cardiomyopathy, congestive heart failure, or ischemic heart disease and
can increase the 5-year mortality rate after a myocardial infarction. 16 Diabetic patients
without heart disease can experience abnormal diastolic function.79
Prevention of diabetes is crucial. Obesity and physical inactivity can increase the
risk of diabetes in men and women. 80-82 Men and women with diabetes are at an increase
for CHD. 83,84 Sullivan et al employed the Medical Expenditure Panel Survey to
determine the association between diabetes and related comorbidities among overweight
and inactive adults. 82The study was a survey conducted on a representative sample from
the United States from 2000-2002. Sullivan reported that inactive and obese participants
were 5.6 (95% CI 4.2-7.8) times more likely to be diagnosed with diabetes and heart
disease than active participants with a normal BMI (20.0-24.9 m/kg2). 82
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Patient History: Physical Inactivity
Physical inactivity is defined by the lack of voluntary movement of skeletal
muscles that results in energy expenditure. 85 and has been shown to cause chronic
diseases 32 such as CHD. Physically inactive people have twice the risk of CHD
compared to physically active people. 31 Physical activity has various physiological
mechanisms to that lead to the prevention of CHD through the improvement of blood
pressure, cholesterol levels, and glucose tolerance. 31,32
Regular physical activity promotes higher levels of high density lipoproteins that
help control low density lipoproteins, improve the efficiency of pumping in the heart, and
retard clotting formation within arteries. 6,32

Patient History: Low Cardiorespiratory Fitness
Cardiorespiratory fitness is associated with the ability of respiration and
circulation to supply oxygen throughout the body during sustained physical activity. 85 86
Research from the Aerobics Center Longitudinal Study (ACLS) has examined the
independent effects fitness has on all-cause and CVD mortality in men 43,46,87-89 and
women; 90 34 results that may be more robust across populations than fatness. 91 Lee et al
reported that lean, unfit men had three times higher risk of dying from CVD(RR=3.16,
95% CI 1.12, 8.92) compared to lean, fit men. 46 Lee also reports that obese, fit men’s
risk for CVD death was not significantly different than lean, fit men. 46
A meta-analysis was published where the authors analyzed 16 different cohorts
with combined person-years over one million. 85 Williams’ meta-analysis reported that fit
individuals have a lower risk for CHD compared to unfit individuals, which is congruent
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with previous findings. 43,46,88 The association between CRF and CHD will be discussed
in more detail later in this chapter.

Patient History: Overweight and Obesity
Overweight and obese status are based on a person’s body mass index. Body mass
index (BMI) was developed by Adolphe Quetelet and is based on an individual’s body
weight and height (weight in kg/height in meters2). 92 Overweight is defined as a BMI of
25.0-29.9 and a BMI of 30.0 or greater is classified as obese. The positive trends in
blood pressure and cholesterol control have unfortunately been partially offset by the
increasing trends in obesity. 14 The prevalence of overweight and obesity has increased
across the world, especially in the United States. 93
Excess weight can lead to an increase in uncontrolled blood pressure which, as
previously stated, puts more strain on the heart muscle. A prospective study conducted
with more than 115,000 female registered nurses showed that a higher BMI increases the
risk for CHD. 94 This nurses’ cohort also showed that weight gain after 18 years of age
increases the CHD risk for middle-aged women. 94 The relative risk for women with
experiencing 20 or more pounds of weight gain since age 18 was 2.7 (95% CI 2.2-3.2)
compared to women who changed less than 5 pounds since they were 18. 94 A metaanalysis involving 31 cohorts concluded that calendar periods had no influence on the
relationship between BMI and CHD and that the strongest affect was attributed to the age
of the population. 93
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Patient History: Family History and Genetics
First degree relatives (siblings, offspring) share roughly 50% of their genetic
variation. 5 Individuals within a specified racial/ethnic group are more likely to share
their genetic variation within their demographic group compared to other individuals
outside their demographic group. 5 Roger et al also reported that 13.3% of adults 20 years
old or greater reported having a first degree relative with a heart attack or angina before
the age of 50. 5
One limitation of investigating this relationship between family history and heart
disease mortality worth noting is survival bias. More plainly, the risk for heart disease
increases with age; individuals without a family history of heart disease may simply live
longer compared to those who have a family history. Another limitation was the potential
for recall bias. The Framingham Study performed a multigenerational cohort study
collecting information on various health outcomes and behaviors. They reported that
among those participants with documented parental history of heart disease, only 75%
accurately reported their family history when asked. 5
Brown et al utilized the longitudinal design of the Framingham Study and their
inclusion of spouses and offspring of original participants to examine the heritability of
phenotypic determinants of CVD. 95 The study stratified on three age groups (Age Group
40 ± 9, Age Group 55 ± 5, and Age Group 70 ± 9) and focused on determining the
strength of heritability of four major CVD risk factors: BMI, height, weight, and systolic
blood pressure. 95 The study found that BMI (h2=0.64), weight (h2=0.63), and height
(h2=0.88) exhibit high heritability when stratified on age. 95

26

Other heritability studies from FHS shows moderate heritability in other CVD
risk factors such as diastolic blood pressure (h2=0.39), 96 subcutaneous abdominal fat
(h2=0.57), 97 HDL cholesterol (h2=0.52), 98 LDL cholesterol (h2=0.59), 98 and total
cholesterol (h2=0.57). 98
Heritability (h2) is the ratio (measured on a scale 0 to 1) of genetically caused
variation to the total variation of a trait or measure. As h2 approaches 1, the heritability
becomes stronger. 95 Heritability of a trait is the proportion of observable differences in a
trait between individuals within a population that is due to genetic differences.

Treatment
Various treatment options for CHD are available depending on the severity of the
problem and the underlying cause. The first form of treatment is to reduce blood pressure
through the employment of drug therapies that regulate heartbeat, normalize cholesterol,
or prevent blood clotting. When addressing high blood pressure, physicians also need to
be aware of hypercholesterolemia and control this condition through lipid-lowering
drugs. 99 Shepherd reported that controlling for high cholesterol significantly reduces the
risk of a nonfatal myocardial infarction (p-value<0.0001) and produces a 32% (pvalue=0.033) reduction in death from CHD. 99
More serious treatment options are available for more severe CHD cases such as
by-passing a failed artery in the heart (heart by-pass), implementation of a stint or balloon
to clear an arterial blockage (angioplasty), or a complete organ transplant for extreme
cases. 6
Inpatient cardiovascular operations and procedures increased 22% between 1999 and
2009. 5
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A comparison analysis of Medicare data from 1992 and 2001 depicted that racial
disparities within the high-priced CVD treatment procedures was still evident 100
although minimizing in some treatment areas. In 1992 the procedure rate difference
between White males receiving a coronary artery bypass graft compared to Black males
was 6.29 (in favor of White males). This disparity between White and Black males was
reduced in 2001 to 5.69, a non-significant 0.60 reduction (according to a multivariable
linear regression). 100
The recent impression cardiothoracic surgeons have is that patients being referred
for coronary artery bypass graft are, on average, “sicker and older” than patients referred
ten years prior. 101 This shift in treatment can be explained partly by extensive previous
literature showing that lower risk patients that may only have one or two-vessel blockage
benefit more from percutaneous coronary intervention 102 while clinical trials document
that patients with a higher baseline risk (usually with triple-vessel disease) are better
treated with coronary artery bypass graft compared to percutaneous coronary
intervention. 103 Ferguson et al analyzed the data from The Society of Thoracic Surgeons
National Cardiac Database from 1990 to 1999. This database included more than 1.5
million adult cardiac procedures and 520 sites. 101 The extensive analysis showed a
decline in risk-adjusted mortality as well as the observed vs expected mortality ratio for
the patients receiving coronary artery graft bypass. 101

Risk Scores
Framingham Risk Score
Investigators from the Framingham Heart Study have developed CHD risk
equations for physicians to employ in order to predict their patient’s risk for developing
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of CHD. 22 These equations were derived for the purpose of application on patients free
of disease. 23 In 1991, the Framingham Heart Study published an update to the previous
risk equations. 22 The more recent equations were derived from a more expansive data
base which included older individuals. 22 The most recent risk score also accounts for the
influence of high density lipoprotein cholesterol, a variable that the Framingham Heart
Study (FHS) has been collecting since 1968. 22
HeartScore
The guidelines that were first issued by the First Joint Task Force of the European
Societies on Coronary Prevention 21 was based on the Framingham Heart Study. 22 The
Task Force had a number of concerns basing their risk chart on this study that included:
1) risk function derived from US data and not European based data 2) definition of
nonfatal endpoints in Framingham Heart Study differed from other definitions of nonfatal
endpoints 3) difficult to adjust the model to account for local variances. 21 The Second
Joint Task Force instigated the development of a risk score that was based on European
cohorts in 12 different countries. 21 The result was a sex and age stratified risk chart that
assessed the individual’s smoking history and cholesterol profile. This risk chart is aimed
to estimate the total cardiovascular risk rather than just CHD 21 and enable its utilization
in different European countries. Although this was a risk score based on several cohorts
throughout Europe, the HeartScore still neglects to account for strong predictors of CVD
such as a diabetes diagnosis 80-82 that are included in the FRS.
Prospective Cardiovascular Münster (PROCAM) Study.
Assmann et al reports that there are certain limitations to the Framingham Heart
Study’s risk chart and that it might not account for family history or triglycerides 20. The
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completion of the Prospective Cardiovascular Münster Study (PROCAM), which
consisted of a cohort of middle-aged men, allowed for a risk score to be compiled to
address Framingham’s limitations. PROCAM accounts for age, low density lipoprotein,
high density lipoprotein, triglycerides, smoking status, diabetes diagnoses, family history
of myocardial infarction, and systolic blood pressure to create a score ranging from zero
to over 60. 20 The PROCAM risk chart adds to FRS by inclusion of family history, but
disregards the difference men and women experience with these risk factors. This lack of
stratification is caused by PROCAM’s limited data on only men that started collection in
1985; compared to Framingham’s initiation of data collection 15 years prior. 22

Summary of Coronary Heart Disease
The mere presence of a risk score does not perfectly correlate with the clinical use
and adherence to the risk score. A 2009 report details the findings of physicians’
attitudes and adherence to CVD risk scores. 24 Sposito et al administered a survey
throughout Europe, Africa, North America, Central America, and South America to
physician groups commonly associated with CHD prevention: cardiologists, general
practitioners, and endocrinologists. 24 The survey consisted of brief questions describing
a hypothetical patient. Forty-eight percent of surveyed physicians indicated that they used
a CVD risk score. 24 Among this 48%, the majority of physicians reported they used the
FRS while less than a combined 15% specified other risk scores 24 such as HeartScore 21
and PROCAM. 20 A primary reason cited by physician’s for not utilizing these risk scores
is that “I don’t believe they add value to the clinical evaluation.” 24 Sposito et al
concludes to stress the importance of early identification of CHD risk and the need for
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refinement of the current risk scores. 24 It is important to recognize that risk scores can
only provide insight in to the risk of CHD and not a robust image. Currently the FRS is
the most common CHD risk score implemented throughout the world. 24 FRS has been
shown to be applicable in various race and ethnic cohorts. 28 Researchers have attempted
to refine the FRS through the addition of other risk factors, only to come up with less
meaningful conclusions than the original risk score. 29,104-108 All of these studies had
various flaws including data compilation, analysis, or reporting. The current study aims
to go beyond these limitations with a more complete, valid data base that will be utilized
to initially assess the prediction power of FRS and then expand on its estimation power
through the addition of cardiorespiratory fitness.

Overview of Framingham Risk Score
The estimation of risk for cardiovascular disease events can be a dynamic and
convoluted task. The FHS wanted to provide a simplified method to predict the risk for
initial CHD events for individuals free of disease. 22,25

Population
The FHS originated in 1948 with a sample of more than 5,000 men and women
free of coronary heart disease at the study’s initiation and residing in Framingham,
Massachusetts. 23 Clinical examinations were conducted every two years. These clinical
exams included blood chemistry values, electrocardiogram, blood pressure, physical
exam, and a thorough cardiovascular examination. 23
The original risk score was derived more than forty years ago and has since been
updated. In 1991 The FRS was updated utilizing the original Framingham population as
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well as the offspring cohort. 22 The inclusion criteria for the population was 1)age 30-74
years at baseline examination; 2)data available on systolic and diastolic blood pressure,
cigarette smoking, cholesterol levels, diabetes diagnosis, and electrocardiogram; and 3)
individual was free of cardiovascular disease at baseline. 23 This study included more
than 5,500 men and women. 22 The Framingham Research group updated the score a few
years later in 1998 utilizing the same population from Anderson et al analysis. 25

Derivation of Variables for Risk Score
Host and environmental factors can contribute to coronary heart disease. These
characteristics include atherogenic personal attributes including serum cholesterol levels,
blood pressure, and glucose intolerance, lifestyle choices (physical inactivity and
nutrition) that may exacerbate these attributes, and preclinical signs for cardiovascular
disease. 23 When the risk factor score was updated in 1991, the risk factors considered
remained the same: age, systolic blood pressure, diastolic blood pressure, cholesterol
(total cholesterol and high density lipoproteins), smoking status, diagnosis of diabetes,
and electrocardiogram to determine CHD. 22 Risk scores also took sex in to account
based on previous findings that men and women experience different risks for coronary
heart disease. 22,23 Blood pressure and cholesterol were defined as continuous variables,
smoking status was dichotomized between currently smoking or quit within past 12
months or otherwise, and diabetes was dichotomized as positive or negative diagnosis. 22
Parametric regression analysis was utilized to determine significant association between
CHD outcome and the aforementioned risk factors; Values for blood pressure and the
ratio between HDL and total cholesterol were analyzed using the log-scale and age for
women was transformed in to a quadratic term. 22 The result from the regression model
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was translated in to a worksheet that clinicians can employ for the approximation of the
five and ten year risk for CHD. 22
Wilson et al continued to refine this worksheet by comparing the prediction power
of continuous risk factors versus categorized risk factors. 25 Blood pressure and
cholesterol level were continuous variables for the 1991 worksheet derived by Anderson
et al 22 and Wilson categorized the variables on five and four levels, respectively. 25
Systolic and diastolic blood pressure was transformed in to a scale for hypertension based
on JNC-V definition; 109 optimal, normal, high normal, hypertension stage I, and
hypertension stage II and III. 25 The higher category for hypertension was chosen when
systolic and diastolic fell in to different groups. 25 Total cholesterol was defined as <200,
200-239, 240-279, and ≥280 mg /dL; high density lipoprotein was defined as: <35, 35-59,
and ≥60 mg /dL; low density lipoprotein was categorized as follows: <130, 130-159, and
≥160 mg /dL. 25 Linear regression was employed to determine the existence of significant
trends within each risk factor 25 and then age-adjusted Cox Proportional Hazard Models
were applied to test the relationship between the risk factors and the outcome of CHD
and assigning point values based on the β-coefficients. 25 Wilson et al tested this
categorization method against Anderson et al’s 1991 model that utilized continuous
variables transformed on the log scale. Sex-specific receiver operating characteristic was
generated for each methodology and a plot was generated to determine the difference
between each model. 25 No statistical difference in predictive power was found for either
method. 25
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Results
The probability for developing cardiovascular disease by age 65 within the
Framingham cohort was 37% for men and 18% for women. 23 The score sheet developed
by Anderson et al assigns points to each risk factor with a point value ranging from -12 to
19; age is the only risk factor stratified by gender. 22 A more detailed description can be
seen in Table 2.4.
Wilson et al refined Anderson et al’s score sheets to incorporate the categorized
variables with a sex-specific final product summarizing an individual’s 10-year CHD risk
that may range from 1% to ≥56% (see appendix Figure 3 for an example of this score
sheet for men). 25 The refined score sheet produced by Wilson et al envelops the same
predictive capability as the continuous model. 22,25 The categorical model also
incorporates the categorical approach utilized by JNC-V 109 to measure blood pressure.
The categorized score sheet lessens the physician burden by allowing the clinician to
utilize either total cholesterol or low density lipoprotein. It is important to note that the
Framingham Heart Study was a free-living population based research and the results
might be altered if the blood pressure or cholesterol levels are aggressively treated.
Wilson et al also evaluated the possible inclusion of other variables in this risk
score. Family history was considered but was found not to be uniformly available within
the birth cohort population. 25 The suggestion to include the presence of estrogen
replacement therapy for postmenopausal women was made but could not be followed
through due to a change in treatment recommendations throughout the decades. 25,110
Regular physical activity and exercise are known to lower your risk of CHD. 39,111,112
The Framingham Heart Study did not capture information on physical activity at the
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baseline examination and the Framingham researchers did not discuss the decision not to
include other risk factors such as BMI. 25
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Figure 2.4. CHD score sheet for men using total cholesterol (TC) or low density
lipoprotein cholesterol (LDL-C) categories. Uses age, TC (or LDL-C), high density
lipoprotein cholesterol (HDL-C), blood pressure, diabetes, and smoking. Estimates risk
for CHD over a period of 10 years based on Framingham experience in men 30 to 74
years old at baseline. Average risk estimates are based on typical Framingham subjects,
and estimates of idealized risk are based on optimal blood pressure, TC 160 to 199 mg/dL
(or LDL- 100 to 129 md/dL), HDL-C of 45 mg/dL in men, no diabetes, and no smoking.
Use of the LDL-C categories is appropriate when fasting LDL-C measurement are
available. Pts indicates points. 113
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Clinical Utilization and Adherence
Prevention of CHD and the reduction of certain risk factors can be crucial to an
individual’s life. FRS is a tool physicians can utilize as a primary source of prevention.
Sposito et al surveyed physicians across the globe to quantify their perspective on risk
scores and the extent that physicians utilize the risk score. Forty-eight percent of
respondents self-reported utilizing the FRS more often than other scores. 24 Of the
remaining 52% of physicians that reported not using a risk score, approximately 75% of
those physicians claimed the risk score ‘took up too much time’ with another 21% adding
that they do not believe the risk score adds anything to the clinical evaluation.’ 24
Physicians were also asked to apply the FRS to a hypothetical scenario. The
physicians were asked to rank the risk of the hypothetical scenario with the options as
low, intermediate, or high. The results were split across the population with the majority
(59%) of physicians ranking the hypothetical case as intermediate; most cardiologists
classified this case as low risk. 24 The disagreement using the FRS varies across countries
and ranged from 29% to 54%. 24
Although there is still a large need to change physicians’ attitudes regarding the
added benefit of risk scores, patient-physician communication and decision making is
still the primary focus. Framingham researchers urge clinicians to exercise caution when
generalizing the FRS. 22,25 One of the limitations cited from the authors and researchers
of the Framingham Study is that the risk measure was created on an American population
comprised of Non-Hispanic White individuals with moderate socioeconomic status.
Extrapolating the FRS for other populations should be done cautiously.
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Validation Within Other Populations
The population recruited for the Framingham Heart Study was derived from a
suburb west of Boston and is comprised of primarily Non-Hispanic White men and
women. 25 However, since its origination, FRS or similar scores have been applied to
various racial and ethnic populations.
The Honolulu Heart Study initiated in 1965with the overall concept of
standardizing cardiovascular examination. 26 The cohort is comprised of Japanese men
born between 1900 and 1919 and updated their World War II Selective Service Files; the
final population with a baseline examination was approximately 8,000 individuals. 26 The
majority of this population were first generation immigrants. 50% never attended high
school and only 15% had any technical or university training. 26
Similar to FRS, all men were free of disease with the primary outcomes consisting
of: myocardial infarction, acute coronary insufficiency, angina pectoris, and death by
coronary heart disease. Independent variables analyzed for inclusion in the final model
were the same as FRS with the addition of skinfold of back and arm, and a diabetes
diagnosis based on history of diagnosis, urinalysis, or glucose intolerance. 26
Although the incidence of CHD in the Honolulu Heart Study was half the
incidence reported in the Framingham Heart Study, the independent relationships to CHD
were very similar. Cigarette smoking, cholesterol levels, and blood pressure all were
significant predictors of CHD but glucose intolerance showed no significant relationship.
26

Similar to the need for standardization of cardiovascular examinations in
Japanese American men that Kagan et al explore, researchers from the University of
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Oklahoma acknowledged the inadequacy of information on cardiovascular disease on
Native American. 114 Lee et al created the Strong Heart Study with an objective to use a
retrospective cohort design and create a standardized risk estimate of cardiovascular
disease. The study consisted of three components: 1. Mortality survey, 2.Morbidity
survey to estimate initial and follow up hospitalizations due to myocardial infarction or
stroke, and 3.Clinical examination .114 The study’s population consisted of Native
American tribes in Arizona, North Dakota, and South Dakota. Men and women in the
study population were segmented in to two age groups comparing 35-44 years (n=5,179)
and 45-74 years of age (n=8,072). 114 The Strong Heart Study investigated similar
covariates to the FRS and found the only significant predictive capabilities between
diabetes diagnosis and a total cholesterol level over 280mg/dL. 28,114
Validation of the Framingham Risk Factor also was done in the Physician’s
Health Study. Male physicians in the United States between 40-84 years of age
(n=22,071) were randomized in a double-blinded, placebo-controlled, study of betacarotene and aspirin. 27 Coronary risk factors were collected through questionnaires prior
to randomization and surveys were mailed to the participants every 6 months. Individuals
would self-report nonfatal CHD incidence, and the non-responders were followed up with
a telephone based survey. 27 Stampfer et al also found similar effects of the FRS
covariates with the exception of smoking. The Physician’s Health Study also reported the
significant joint effects HDL and total cholesterol have on CHD’s relative risk. 27,28
D’Agostino et al evaluated the level of agreement between the FRS applied to the
Framingham Heart Study cohort and the FRS applied to non-Framingham Heart Study
populations. They concluded that the level of agreement was reasonably sound between
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the predicted and actual CHD events, with the exception of the study implemented using
the Japanese American cohort. 28 The suggestion from D’Agostino and his co-authors for
future application of the FRS to non-Framingham Heart Study populations was to obtain
the cross-sectional information on risk factor prevalence in conjunction with population
rates of CHD over time 28. However, application of the FRS to dissimilar populations is
not the only form of modification researchers have undertaken since the FRS’s
development.

Potential Risk Score Modifications
There are various risk factors that have a significant relationship with CHD and
other cardiovascular events. However, it is not enough for these risk factors to have
independent predictive power. The risk factor has to improve the predictability traits that
the traditional, FRS, encompasses.
A recent review article assessed various risk scores that claimed to improve the
prediction power of the Framingham Risk Score. The review contained studies that
include one or more factors in addition to the original variables present in the FRS. 104
Articles were included if they demonstrated analyses comparing the FRS performance
against the predictive performance of the modified FRS. 104 The review article included
articles making additions to the FRS: BMI, alcohol intake, and racial group; deletions
that included diabetes diagnosis and blood pressure definition; and also the modifications
to the definitions of smoking to include pack years, and blood pressure to include the
prevalent hypertension diagnoses. 104
Pischon et al investigated the predictive power of C-reactive protein (CRP) and
the feasibility to substitute this for low-density lipoprotein cholesterol measure. 29 CRP
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has been shown to be a strong independent predictor of cardiovascular events including
myocardial infarction and stroke. 115,116 The study population consisted of more than
27,000 participants age 35-65 years in the city of Potsdam, Germany between the years
1994-1998. 29 Myocardial infarction and stroke were self-reported by the study’s
participants and CRP was measured through highly sensitive assays and then applied to
the FRS. 29 Cox regression analysis showed that the FRS plus CRP was a significant
prediction model for myocardial infarction and stroke although the inclusion of CRP did
not add prediction power to the original FRS. 29 However, a limitation to Pischon et al’s
publication was the lack of calibration or test for goodness-of-fit through comparison of
the FRS to Pischon’s revised risk score.
Ingelsson investigated apolipoprotein’s predictive power in FRS instead of
including low-density lipoprotein. 106 The Framingham Offspring Study population was
used for this analysis and the lipid measures were captured after a 12-hour fast. 106 The
model including the apolipoproteins was subjected to a test for Goodness-of-Fit as well
as model calibration. Goodness-of-Fit was analyzed through the C index produced by the
Cox models. 106 The C index is calculated through the summation of the concordance
values divided by the number of comparable pairs and has been shown to be analogous to
the area under the curve obtained through the receiver operating characteristic curve. 117
The study showed that the apolipoproteins predicted 10 year CHD risk well but there was
no significant difference in prediction ability between the traditional cholesterol measures
and the apolipoprotein 106 and therefore no benefit of the substitution. This is similar to
other findings that attempted to include CRP in the FRS. 105,118
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Instead of attempting to modify the FRS with biological factors, Gallo et al
studied the value of augmenting the FRS with social factors that may increase the risk of
CHD. 30 Gallo et al. explored the effect of involuntary job loss after the age of 50 may
have on 10-year risk on myocardial infarction and stroke. A Cox regression model was
used to analyze the first ten years of data in the US Health and Retirement Survey with
the outcome as self-reported myocardial infarction or stroke. Job loss was the main
independent variable and was treated as a time dependent variable. 30 Gallo and his
associates found that individuals who lost their job involuntarily had a 2.48 times higher
risk (95% CI 1.49-4.14) for myocardial infarction and a 2.43 high risk of stroke
compared to individuals who did not experience involuntary job loss. 30 Although this
study displays the predictive ability of the FRS augmented with job loss, Gallo et al did
not perform goodness-of-fit tests to determine if this model was truly a better predictor of
10 year cardiovascular disease risk than the original FRS.

Summary of Framingham Risk Score
Framingham Risk Score has been proven to be a strong predictor of CHD risk in
dissimilar populations. 26-28,114 Researchers have also attempted to improve the FRS
through modification of current risk factors or the addition/deletion of FRS covariates
29,30,105,106,118

although various limitations did not allow these studies to achieve strong

agreement with FRS or producing a more robust predictive model than FRS.
During Wilson et al’s augmentation of the 1991 FRS model, the analysis tested
the addition of other risk factors. 25 Physical activity has been shown to have a predictive
effect on CHD 32 although the Framingham Heart Study did not capture this information
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at the baseline examination prohibiting its inclusion in the model. 25 Another risk factor
that has a well-documented significant protective effect over CHD mortality and nonfatal CHD events is cardiorespiratory fitness. 39,43,87,88,119

Overview of Cardiorespiratory Fitness
Physical Activity
Physically active individuals have a lower risk for coronary heart disease
compared to people less physically active. 54 Berlin et al conducted a meta-analysis on
previous literature surrounding physical activity. Her analysis grouped the papers in to
work-related and leisure physical activity while examining non-fatal coronary heart
disease, fatal coronary heart disease, and myocardial infarction. 54 Summaries and
characteristics from 27 different cohorts were analyzed to generate a Mantel-Haenszel
Odds Ratio. 54 One pattern that emerged from the data was an inverse dose-response
association; increasing physical activity decreased the risk for CHD. 54 In nonoccupational physical activity, nine studies reported that low physically active individuals
have a pooled relative risk of 1.5 (95% CI 1.4-1.7) for CHD compared to high physically
active individuals. 54
A more recent meta-analysis was done by sports medicine researchers in Japan.
Their focus was to determine the effects of physical activity on women’s health and
preventions of CHD in women, since physical activity has been shown to have different
effects in women and men. 33 Oguma and colleagues identified 30 articles originating
from 23 different studies, the majority with a cohort study designs. 33 The paper
confirmed that physical activity has a protective relationship with CHD in women.
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Physical inactivity has been shown to cause CHD. 32,67 A recent review published
focused on the biological mechanisms behind the link of physical activity and exercise to
CHD. In essence, Booth and his contributors reported that the lack of physical activity or
decrease from an active lifestyle to a sedentary lifestyle can cause a decreased turnover of
energy stores and decreased lipid turnover causing hyperinsulinemia to occur. 67
Hyperinsulinemia can lead to several other conditions including accumulation of
adiposity in the abdominal region, insulin resistance, metabolic syndrome, and type 2
diabetes with the latter two conditions leading to an increased risk of CHD. 67

Limitations of Physical Activity
As noted in the meta-analysis conducted by Oguma et al, measuring physical
activity is not entirely standardized. Physical activity has been categorized differently
across studies which may vary the results and makes comparisons to previous findings
difficult. 33 In addition to this, the primary components that calculate the volume of
physical activity (duration, intensity, and frequency) performed cannot be captured
accurately. 33 This type of misclassification is common in physical activity 120 and can
dilute the effect size determined between physical activity and CHD. 33 It could be this
misclassification that has caused various results of physical activity’s effect on CHD and
all-cause mortality throughout the literature. 41 Although Kampert et al presented that
physical active men had a lower relative risk of all-cause mortality compared to
physically inactive men; this significant relationship between physical activity and allcause mortality was not present in women. 41
In a meta-analysis that examined 16 cohorts totaling more than 1 million personyears, the authors were able to assess the various affects physical activity and
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cardiorespiratory fitness may have on CHD. 85 The risk reduction for fitness was
significantly greater than the risk reduction for physical activity. 85 This report discusses
how physical activity and cardio respiratory fitness have significantly different
relationships on CHD risk, although both are protective factors. 85 Cardiorespiratory
fitness (CRF) resolves the limitation of physical activity measures not being able to
capture energy expenditure consistently.

Cardiorespiratory Fitness: Definition
Cardiorespiratory fitness (CRF) is defined as the ability of the circulatory system
to supply and utilize oxygen during sustained physical activity. 38 CRF is typically
measured in epidemiological studies through maximal or submaximal exercise tests 39.
CRF has been shown to be strongly correlated with measured maximal oxygen uptake in
women (r=0.94) 121 and men (r=0.92)122 and is the most accepted index of CRF. 43 CRF is
typically categorized using treadmill performances normalized based on age and sex. 43
CRF has been shown to be protective against all-cause mortality even when taking in to
account various health conditions. For example, Blair et al described that current
smokers with high CRF have reduced relative risk of all-cause mortality compared to
current smokers with low CRF. 43 In an observational cohort of more than 6,000 women,
low CRF was described as being a significant predictor of type 2 diabetes incidence
cases. 34

Cardiorespiratory Fitness: Comparison with Physical Activity
Usual physical activity habits are the primary determinant of fitness 34 in addition
to CRF’s genetic component. 35-37 Church et al 123 showed that even a modest exercise
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program of 4 kcal/kg a week increase in physical activity was associated with significant
improvement in CRF. A recent meta-analysis was performed to compare the effects
physical activity and CRF had on CHD. 85 Williams plotted the relative risk (Figure 2.5)
as functions of the cumulative percentages within the samples when ranked from least
active or fit to most active or fit creating a weighted average for the 16 physical activity
cohorts and seven CRF cohorts. 85 Physical activity presented a linear relationship with
CHD with a 1% increase in physical activity being equivalent to a 0.0031 reduction in
CHD relative risk. 85 CRF also produced a protective effect on CHD risk although, unlike
physical activity’s relationship with CHD, CRF did not have a linear association with
CHD and could be more appropriately described as a dose-response curve with the
largest improvement occurring between unfit and moderate fitness. 85 The relative risk
reduction for CHD was almost twice as much for CRF than for physical activity (Figure
2.5). 85 This conclusion is similar to other findings and reviews of physical activity
compared to CRF and the relationship with CHD and other outcomes such as all-cause
mortality. 39,124 In preliminary multivariate modeling analyses using the Aerobic Center
Longitudinal Study (ACLS) database, fitness still showed a significant protective
association with all-cause mortality even when physical activity and comorbidities were
included 39,120.multivariate modeling analysis employing the Aerobic Center Longitudinal
Study (ACLS), fitness still showed a significant protective association with all-cause
mortality even when physical activity and comorbidities were included. 39,120
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Figure 2.5. Estimated dose-response curve for the relative risk of either
coronary heart disease (CHD) or cardiovascular disease (CVD) by
sample percentages of fitness and physical activity. Studies weighted by
person-years of experience (Williams 2001)

Cardiorespiratory Fitness: Predicting Capabilities
All-Cause Mortality
One of the first articles to publicize the protective relationship CRF may have on
adverse health outcomes originated from the Aerobic Center Longitudinal Study (ACLS)
report in 1989. 43 More than 13,000 participants, comprised of mainly White males,
completed a thorough medical examination that included family history, recording of
current medical diagnoses, blood chemistry, and maximal exercise test. The maximal
exercise test was used to estimate maximal oxygen uptake and was performed on a
treadmill with start position of 0% grade and 88m/min. 43 The treadmill increased to 2%
after the first minute, and then 1% each minute for 25 minutes. After 25 minutes was
completed, the incline did not change and the speed began to increase 5.4 m/min until
termination. The ACLS population was divided in to age and sex specific quintiles. 43
Participants were followed from their first clinic visit through 1985 to determine the
occurrence of the event, all-cause mortality. 43 The study population was divided in to
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quintiles of fitness and then analyzed for joint effects of fitness and various comorbidities
on all-cause mortality. 43 In men with cardiovascular disease, there was a significant
protective linear trend relationship between CRF and all-cause mortality. 43 Women with
cancer in the unfit group had a relative risk of all-cause mortality of 16.3 compared to
women in the fit group. 43
Diabetes
The Centers for Disease Control and Prevention has predicted that American
lifestyle and choices coupled with improved diabetes management, will result in an
estimated prevalence of diabetes mellitus of 48.3 million by the year 2050. 125 Obesity
and physical inactivity are two strong predictors of diabetes incidence. 80,82,126 A large
prospective cohort focused on determining the independent and joint associations CRF
and obesity may have on the incidence of type 2 diabetes in American women. 34 More
than 140 women developed diabetes in a 17 year follow up period. 34 Age-adjusted
incidence rates were calculated for increments of CRF and the results showed that
women with a low exercise capacity (<7 METs) had a three times higher risk of
developing type 2 diabetes compared to women with a higher exercise capacity (≥10
METs). 34 When the combined effects of CRF and BMI were analyzed, normal-weight
(BMI <25 kg/m2) unfit women (lowest CRF tertile) did not present an increased risk for
diabetes incidence while overweight/obese (BMI≥25 kg/m2) unfit women had twice the
risk for diabetes incidence; both groups were compared to the referent group comprised
of normal weight fit women. 34
A similar prospective study with 18 years of follow up was conducted in men 127
and found CRF protective against incidence of type 2 diabetes. Men in the upper two
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CRF quintiles with a fasting glucose <100 mg/dL had a 60% decreased risk of
developing diabetes compared to unfit men with similar fasting glucose levels, 127 which
was similar to findings from other study populations. 44,112,128,129
Diabetes is not commonly recorded as the primary cause of death. 130-133 A 1992
study reported that, among individuals with a history of diabetes, diabetes was captured
as the cause of death only 36% of the time. 133,134 A more recent study from 2006
reported that diabetes was recorded on 39% of death certificates and was only listed as
the underlying cause of death on 10% of decedents with diabetes. 135 It is much more
likely for cardiovascular disease to be listed as the primary cause of death for individuals
with diabetes than for diabetes to be listed as a cause of death. 135
This limitation in vital statistics has led researchers to investigate all-cause or
cardiovascular disease specific mortality within a subpopulation with a diabetes
diagnosis. 40,136 All-cause mortality was the outcome of interest for a study published in
2000 investigating the predictive effects of CRF and physical inactivity in men with type
2 diabetes. 136 Average follow-up time for 1,260 diabetic men was 12 years, and it was
noted that 180 individuals died during the study period. 136 A fully adjusted model
reported that low fit, diabetic men had twice the risk of all-cause mortality compared to
fit men. 136 Similarly, physically inactive men with diabetes had 1.7 times higher risk for
all-cause mortality compared to their physically active counterparts. 136
A comparable study including more than 2,300 men in a subpopulation with a
diabetes diagnosis but no history of stroke or myocardial infarction; 179 deaths due to a
cardiovascular event were identified in this population. 40 When CRF was analyzed as a
protective factor while controlling for body mass index, it was shown that low fit males
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categorized as normal weight (18.0<BMI<25.0) had a higher risk for CVD-specific
mortality (HR 2.7, 95% CI 1.3-5.7) compared to fit males with normal weight. This
significant relationship was also present in low fit males classified as overweight (HR
2.7, 95% CI 1.4-5.1) or class I obese (HR 2.8, 95% CI 1.4-5.1) 40. CRF’s protective
relationship with type 2 diabetes incidence may be explained through glucose
homeostasis. 137,138 CRF could assist in glucose homeostasis by improvement of blood
flow, fiber size, or kinetics involved in insulin and noninsulin signaling. 138
Cancer
A prospective observational cohort was employed to determine the relationship of
CRF and cancer mortality. 41 The prospective observational study contains a large group
of men (n=25,341) and women (n=7,080) with an average age around 42 years and
originating from a middle to upper socioeconomic status. 41 The cohort is also from the
ACLS and the method of obtaining CRF is aforementioned. 41,43 This report stratified
CRF in to quintiles and concluded a significant protective linear trend for all cancer
caused mortality for both men and women. 120 The treadmill maximal exercise test is an
objective measure of fitness and minimizes the misclassification common for the
subjective, self-reported measures of physical activity. 41,85 However both have shown
protective relationships against cancer including prostate, colon, lung, and breast cancer.
139,140

CRF’s strong linear protective trend against all types of cancer may be caused

through the enhancement of the immune system. 120 However, Kampert et al was careful
to note that this protective relationship may be mediated by genetic predispositions. 41
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Self-Rated Health
Self-rated health (SRH) is a subjective measure that is used to capture an
individual’s perception of their health. This perception can incorporate biological,
psychological, and social constructs that may be unavailable to the external observer. 141
SRH has been shown to be independently associated with all-cause mortality. 142 In a
recent large cohort study, SRH was also determined to have a dose-response relationship
with CRF predicting all-cause mortality 141. The researchers analyzed this significant
protective relationship taking in to account the presence of a chronic medical condition
including diabetes, hypertension, cardiovascular disease, and cancer. 141 Men diagnosed
with one or more chronic health conditions and a good/excellent SRH experienced a
lower risk of all-cause mortality compared to men with one or more chronic health
conditions and a poor/fair self-rated health. 141 The relationship between SRH and allcause mortality was only attenuated when CRF was added to the model. When compared
to unfit men reporting poor/fair SRH, fit men with good/excellent SRH had a 58%
smaller risk of all-cause mortality. 141

Quality of Life
Along with CRF’s protective effect on diabetes, 34,127 cancer, 41,143 and chronic
obstructive pulmonary disease,144 research has shown the improvement of overall quality
of life. 145 Previous epidemiological studies have reported a protective association
between CRF and quality of life. 146-148 Martin et al surpassed the conclusions from these
studies and investigated the effects RF may have on quality of life with The DoseResponse to Exercise in postmenopausal Women (DREW) randomized controlled trial.
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145

This study population encompassed more than 400 women age 45-75 years. The

women were randomized in to four different groups and the Medical Outcomes 26-Item
questionnaire was utilized to measure quality of life. 145 At baseline, there were no
significant differences in the mean scores of the DREW participants and the national
mean. 145 Women were either assigned to a control group that did not perform any
exercise, or to one of three physical activity intervention groups that expended 4, 8, or 12
kcal/kg of body weight each week. 145 The results depicted a positive dose-response
relationship between CRF and quality of life; this relationship was not attenuated by
weight change. 145 As the demographics for the 65 years of age or older population begin
to shift, this paper holds important public health implication for this sub-population. The
aging population of the United States can benefit from exercise and improved CRF by
preventing certain chronic conditions and improving their quality of life.

Coronary Heart Disease
A 1987 review article summarized the protective effects of habitual physical
activity and coronary heart disease. 149 The review paper concluded that there was a
significant effect between physical inactivity and CHD. 149 The authors continue to state
that physical activity is a complex measure without standardization. 149 150 The lack of
standardization leads to imprecise findings with only 66% of the reviewed literature
showing a significant relationship. 149 On the other hand, CRF is a very objective measure
with a standardized operating procedure and variable definition. 150
An early study portrayed the significant effect CRF has on CHD risk factors in
women. 42 Women ages 18-65 years who completed a comprehensive medical exam
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between 1971 and 1980 were included in the regression analysis to determine the
relationship between CRF and CHD, a relationship already found to be significant in
men. 47-49 The CHD risk factors employed in the analysis were based on the Framingham
Risk Score. 23 CRF was shown to have significant impact on the CHD risk factors
including current smoking, total cholesterol, HDL cholesterol, and blood pressure. 42
Ekelund continued the study of this association through the utilization of the Lipid
Research Clinics Prevalence Survey. 45 The primary aim of this study was to determine
the relationship physical fitness, obtained through a maximal exercise test, has on
coronary heart disease mortality. 45 Cox proportional hazard models were used in a
cohort of approximately 4,000 men divided in to a healthy group and a group with
cardiovascular disease diagnosis. 45 Healthy men with a higher CRF were shown to have
a lower CHD and CVD mortality compared to healthy men with low CRF; similarly, men
with a CVD history and low CRF are 5.6 times more likely to die from CHD (95% CI
2.5-12.6) or 4.8 times more likely to die from CVD (95% CI 2.5-9.2) compared to men
with a CVD history and high CRF. 45 Ekelund et al concluded that mortality was higher
in the least fit group regardless of health history and that physical fitness and physical
training improve heart rate, heart rate recovery, and improve myocardial oxygen supply.
45

This study provides further evidence to Oja et al’s results from a physical training

program in men. 47 The men were divided up in to four training groups based on their
preference for type of exercise with two groups serving as the control training group
whom did not receive any exercise. At the end of the 18 month training, a significant
change (p-value <0.001) was seen in the experimental groups regarding their heart rate
recovery, and max VO2. 47
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To better assess the risk factors for CHD mortality and the impact CRF may have,
Lee et al (1999) conducted an analysis to examine the relationship between body
composition, CRF, and CHD mortality. Approximately 22,000 men who completed a
medical examination between 1971 and 1989 received a body composition assessment
and reached ≥85% of their age-adjusted maximal heart rate during a treadmill test. 46
Body composition of these men was measured either through hydrostatic weighing,
skinfold-thickness measurements, or both and percentage of body fat was calculated with
Siri’s 151 two-component model. Body composition was defined as a three level variable:
lean (<25th percentile), normal (25th to <75th percentile), or obese (≥75th percentile).
Hazard ratios were adjusted for smoking habit, alcohol use, and parental history of heart
disease with the referent group represented by fit, lean men. 46 A significant interaction
was reported between body composition and CRF. Unfit lean men had a significantly
three times higher risk for CHD mortality compared to fit lean men; unfit men with
normal body composition had a 2.94 (95% CI 1.48, 5.83) times higher risk compared to
fit lean men. 46 The largest effect was found in unfit obese men who had a four times
higher risk for CHD mortality compared to fit lean men. 46 Although there were
significantly higher risk of CHD mortality across the body composition groups, this
significant relationship was attenuated in fit men. Fit men with a normal body
composition had a 1.43 (95% CI 0.77, 2.67) higher risk of CHD mortality compared to fit
lean men while fit obese men had a 1.35(95% CI 0.66, 2.76) times higher risk compared
to referent group. 46
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Figure 2.6. Cumulative Rate of Death from Cardiovascular Disease
in Health Men, According to Quartiles of Stage 2 Exercise Heart
Rate (Ekelund, Haskell et al. 1988)

These findings build on a previous report from Ekelund et al 45 who investigated
the relationship between CRF and CHD in asymptomatic men. A treadmill maximal
exercise test was used to determine fitness category and the participants were divided in
to four categories depending on their heart rate during the second stage of the treadmill
test with the fourth quartile representing the least fit individuals. 45 The participants were
followed for nine years for event occurrence (CHD mortality). A cumulative growth
curve for CHD mortality depicts the most fit group (first quartile) having the least risk
compared to the fourth quartile. 45
The biological mechanisms behind this protective relationship is primarily based
on peripheral mechanism 152,153 such as improvements in skeletal muscles and
enhancement in arterial oxygen content. 153 Research has shown that CRF can increase
the double-product threshold for ischemic ST-segment depression, 154,155 a decrease in the
magnitude of ST depression, and a diminished maximal ST depression. 154 CRF may also
have a positive effect on coagulation 156,157 and protect against thrombosis. 45
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This protective relationship between CRF, CHD diagnosis, and CHD cause
mortality has been demonstrated numerous times. 88,111,119,123,158-161 Despite this strong
and continuous relationship, the American Heart Disease and Stroke do not mention
CRF’s protective effects against CHD in their annual report. 5,6,162

Cardiorespiratory Fitness: Utilization in Coronary Heart Disease Risk Factor Scores
Barlow et al recently investigated prognostic factors of long-term cardiovascular
risk in “low risk” men and women. 163 Low risk for coronary heart disease was defined
utilizing the 10-year risk of CHD <10% by the Framingham Risk Score. 163 Through the
analysis of cardiorespiratory fitness, Barlow et al showed that a 1-MET increase in CRF
resulted in an 18% lower risk of CVD mortality during a 30 year follow up period. 163
Gupta et al sought to determine CRF’s contribution to traditional CHD risk
factors 50. Gupta utilized the ACLS cohort with data ranging from 1970 through 2006.
The researchers utilized a traditional CHD risk factor model that adjusted for age, systolic
blood pressure, diabetes, total cholesterol, and smoking status 50 and measured the
predictability of the traditional model on the ACLS cohort and the predictability of the
traditional risk factor score after the addition of CRF. Harrell’s C statistics were
calculated for each model. All variables included in the traditional risk factor score and
all quintiles of CRF were significant with CHD mortality. 50 When comparing the
traditional versus CRF augmented model in men, the CRF augmented CHD risk factor
model correctly reclassified participants with CHD death based on their 10-year risk 50.
For instance, among male participants with CHD death, the CRF augmented risk model
reclassified 49 high risk participants that the traditional model classified as low risk. 50
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A potential limitation of this study is the use of a very basic model to represent
the traditional CHD risk factor model. Gupta et al’s traditional CHD risk factor model
accounts for variables that other popular models, such as the Heart Study, 21 do not while
neglecting to include significant CHD risk factors that other models include. A popular
CHD risk factor score derived from the PROCAM cohort adjusts for similar covariates in
Gupta et al’s study with the addition of family history of myocardial infarction, HDL, and
LDL. 20 The FRS adjusts for sex similarly to Gupta et al and also includes diastolic blood
pressure and high density lipoproteins in their risk calculation. 22
Each CHD risk factor model has its own specific limitations. Gupta et al reported
the improvement in calibration and risk classification CRF added to their ‘traditional’
risk score derived from the ACLS cohort. 50 Other researchers have taken the FRS and
added covariates such as apolipoproteins, 106 C-reactive protein, 29 and social factors. 30
The aforementioned evidence and research states the strong protective effect CRF has on
CHD. Previously presented literature also reports the validity of the FRS. The
culmination of this literature suggests that the addition of CRF in the Framingham Risk
Score may provide a stronger predictive model than the original equation.
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CHAPTER III
METHODS

This research encompasses three manuscripts focusing on the predictive
power of cardiorespiratory fitness. The overarching goal is to create a prediction equation
that includes CRF and is modeled after the Framingham Heart Study’s Framingham Risk
Score. Each manuscript addresses specific research topics through the utilization of the
Aerobics Center Longitudinal Study data.

Aerobics Center Longitudinal Study (ACLS)
ACLS is an ongoing, cohort study that encompasses a large group of men and
women. The participants were patients of the Cooper Clinic, where they received a
preventative medical examination and counseling on health behaviors during periodic
visits. The Cooper Clinic serves anyone who elects to come for an examination and
patients come from all 50 states. During the patients’ medical examination, they were
informed of the ACLS cohort study, asked to participate, and, if they agreed to
participate, consented to follow-up surveillance.
The participants were examined at least once during 1970 to 2003 at the Cooper
Clinic, Dallas, TX. The cohort consists of mostly individuals within the middle and upper
socioeconomic groups with approximately 80% holding college degrees. 41 The mean age
of the cohort is 42 years at baseline and consists primarily of Non-Hispanic White
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(>95%) individuals. Although a large number of women were enrolled in ACLS, the
majority of patients were men (~75%). The following primary inclusion criteria were
used:
1. Age at baseline examination between 30-74 years
2. Complete data for outcome and predictor variables
3. Free of CHD diagnosis or cancer diagnosis at baseline
Women were excluded from analysis due to the small proportion of events. The
sample population for Hypothesis I is larger compared to the sample population utilized
for Hypothesis II and III. The change in sample size is cause by second inclusion item
and ensuring there was not missing data. Hypothesis II and III include the CRF variable
that is missing in 13.61% of the sample population for Hypothesis I.
While ACLS is not a representative sample of the entire US population, a
comparison of median values of specific physiological variables show similarity to
representative population data. 164 A comparison between ACLS and two large
population based cohorts found that ACLS’ results were similar to the results of the Lipid
Research Clinics Prevalence Survey and the Canada Fitness Survey. 165 A notable
advantage of ACLS’ homogeneity is controlling for potential confounding by
demographic characteristics such as education, socioeconomic status, and race/ethnicity.
Although ACLS’ homogeneity characteristic improves the internal validity,
generalizations must be made cautiously and future research should be conducted in more
diverse populations.
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Baseline Examination
Trained technicians followed standardized protocols for each measurement. The
baseline clinical exam included a personal and family medical history, anthropometric
measurements, a 12-hour fasting blood chemistry including glucose and cholesterol
measurements, ECG, blood pressure assessment, and a maximal exercise test 112,164,166.
Smoking was assessed through a standardized questionnaire and participants were
classified as current or non-smoker.
CRF was determined using the Balke maximal exercise test 167. Treadmill time
converted to METs is analogous to peak VO2 121 and is an accepted object laboratory
measure of CRF. At initialization of test, the treadmill speed was 88m/min for the first 25
minutes. The initial grade of the treadmill was set at 0%, increased to 2% after the first
minute, and then increased 1% grade for the second minute and continued this pattern of
progression for each subsequent minute until 25minutes elapsed. After 25 minutes, the
treadmill’s grade remained constant and the speed increased at the rate of 5.4m/minute
until termination of the exercise test. Technicians encouraged participants to give
maximal effort. The following regression formula was employed to convert maximal
treadmill time to METs 48:
(

)

One MET is equal to energy expenditure of an average person at rest. 168 Factors other
than physical activity may influence both health status and fitness levels through various
biological pathways. Because of this, CRF provides an objective measure of recent
physical activity habitat compared to self-report physical activity levels; CRF also offers
an objective measure of the physiological consequences a sedentary lifestyle may have
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and CRF is less prone to misclassification bias. Many ACLS participants have several
clinical examinations at varying intervals. Table 3.1 depicts the main assessments
included in their clinical exam and interview.

Table 3.1. Data available on Cooper Clinic patients (baseline and repeat visits)
3. Brief nutritional pattern questionnaire
A. Demographics
Age, Sex, Race, Education, Income,
4. Alcohol intake
Occupation, Marital Status
5. Extensive exercise and sports
participation questionnaire
6. Weight history
B. Medical History
1. Medication history
2. Extensive series of questions on past or D. Laboratory
present diseases/conditions
1. Maximal exercise treadmill test (ECG,
3. Hospitalizations
heart rate, and blood pressure during
4. Physician visits
exercise and recovery)
5. Days lost from work
2. Pulmonary function
6. Family medical history
3. Body composition (7 skinfolds, girths,
and hydrostatic weighing)
4. Blood chemistries (lipids, glucose, uric
C. Health Habits
1. Smoking history
acid)
2. 3-day diet record
5. Urinalysis
6. Height and weight
7. Physical examination (complete
physician’s examination findings
including ECG interpretation)

Framingham Risk Score (FRS)
FRS was derived from the Framingham Heart Study, which is an ongoing
observational study that initiated in 1948 and primarily recruits residents of Framingham,
Massachusetts. 23 The Framingham Heart Study involved clinical exams conducted every
other year. The inclusion criteria applied to the Framingham Heart Study to derive the
study population were 1)age 30-74 years at baseline examination; 2)data available on
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systolic and diastolic blood pressure, cigarette smoking, cholesterol levels, diabetes
diagnosis, and electrocardiogram and 30individual was free of cardiovascular disease at
baseline. 22 The most recent FRS is presented with categorical variables for hypertension,
total cholesterol, high density lipoprotein, smoking, and diabetes. 25
The main outcome of the FRS was a CHD event defined as a myocardial
infarction, coronary insufficiency, or CHD death. These events were recorded from selfreport or medical chart review. The original FRS has been updated since its origin in
1976. 23,25 FRS stratifies by sex and adjusts for age. Age is treated as a continuous
variable within the survival model. Anderson et al 22 updated the FRS and the risk factors
included the continuous variables: systolic blood pressure, diastolic blood pressure, total
cholesterol, high density lipoproteins, and dichotomous variables for smoking status and
diagnosis of diabetes. In 1998 all risk factors, with the exception of age, were analyzed as
categorical variables. 25 The predictability of the categorical FRS was compared to the
FRS containing the continuous variables and the results showed that the more recent
version maintained Anderson et al’s predicting power 25. The risk factors included in the
age-adjusted analysis were: hypertension, total cholesterol, high density lipoprotein,
smoking status, and diabetes diagnosis.

ACLS Measurements
Definition of Outcome
Coronary heart disease (CHD) was the primary endpoint being investigated. CHD
was defined as the self-report of myocardial infarction or revascularization (including,
bypass, coronary balloon, angioplasty, or stent) or death due to CHD. Deaths among
study participants were identified from the National Center for Health Statistic’s National
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Death Index. International Classification of Disease (ICD) codes: 410.0-414.0 (Ninth
edition) and I20-I25 (Tenth edition), were used to identify CHD as the primary cause of
death. In accordance with FRS’ follow-up time definition, the maximal follow up time
was 12 years. The 12-year follow up was used in the regression and survival analysis and
then adapted to provide a 10-year CHD incidence estimates.

Derivation of Covariates
The covariates considered for analysis in the ACLS population mimicked the
variables included in the recently-updated Framingham Risk Score. Hypertension (HTN)
was defined through the categorization of systolic blood pressure and diastolic blood
pressure. Systolic blood pressure was categorized in to five levels: <120 mm Hg, 120-129
mm Hg, 130-139 mm Hg, 140-159 mm Hg, or ≥160 mm Hg. Diastolic blood pressure
was categorized in to five levels: <80 mm Hg, 80-84 mm Hg, 85-89 mm Hg, 90-99 mm
Hg, ≥ 100 mm Hg. When an individual’s blood pressure fell into different categories for
systolic and diastolic blood pressure, the higher category was chosen for categorization.
(For example, if a participant’s blood pressure was 130/80 (SBP/DBP), the corresponding
categories for systolic blood pressure would be 2, and the diastolic blood pressure
category would be 1. To determine the HTN category, the highest classification would be
chosen, in this example the HTN categorization would be 2.) HTN definition was made
without regard to a participant’s use for antihypertensive medication. The definition of
HTN parallels FRS’ definition. 22,25
Total cholesterol was grouped in to four levels: <200 mg/dL, 200-239 mg/dL,
240-279 mg/dL, and ≥ 280 mg/dL. High density lipoproteins were categorized as: <35
mg/dL, 35-59 mg/dL, and ≥ 60 mg/dL. A 12-hour fasting glucose >140 mg/dL classified
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an individual as having diabetes. Smoking status was dichotomized as current or nonsmoker. All categorizations and definitions were analogous to FRS’ covariate groupings.
25

The volume of participant-level measurements is rare and unusual in a large,
single center epidemiological study. The major assessment variables cover a range of
clinical and physical examination data, although limitations are still apparent. One
limitation of ACLS’ measurements is the lack of nutritional and dietary measures. A
second limitation is the absence of participant’s medication information. Despite these
limitations, the analyses employed for this research do not require either piece of data.
The ACLS study protocol was annually reviewed and approved by the Cooper
Institute Institutional Review Board.

PAPER 1: Framingham Risk Score applied to the Aerobic Center Longitudinal
Study (ACLS)
Purpose
This manuscript will address Hypothesis 1: the Framingham Risk Score will be a
significant predictor of CHD events for men within the ACLS population.
Study Design
Analysis were performed using the ACLS prospective cohort. Predictor variables
were determined at baseline examination and each participant and follow-up was
conducted to ascertain information on the occurrence (or non-occurrence) of a CHD
event.
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Study Population
Men who completed a baseline examination at the Cooper Clinic in Dallas, TX
between 1970 and 2003 and were free of CHD were included in the study population.
Participants were volunteers and consented to follow up examinations prior to baseline
exam. The exclusion criteria initially applied omitted individuals age less than 30 years or
older than 75, with a body mass index less than 18.5kg/m2, a history of CHD, stroke, or
cancer at baseline, and follow-up time less than one year. Individuals needed complete
data on all variables of interest: systolic and diastolic blood pressure, cigarette smoking,
cholesterol levels, diabetes diagnosis, and electrocardiogram. Participants must have
completed a baseline examination between 1970 and 2003 and all participants were
followed until death or 31 December 2003. Men comprised 76% (n=34,557) of the study
population (n=45,833). Women were excluded from analysis due to the small number of
CHD events (n=45) among this subgroup. The average age for men was 44 years. The
majority of participants were Non-Hispanic, white, and well-educated. The Cooper
Institute’s Institutional Review Board annually reviewed and approved the ACLS
protocol.
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Figure 3.1. Study flow for Paper 1 and Aerobic Center
Longitudinal Study (ACLS) inclusion criteria depicting
final sample size and coronary heart disease (CHD)
event frequency. Men with complete Framingham Risk
Score (FRS) data and body mass index (BMI) ≥ 18.5
kg/m2 were included in the analysis.

Measures
Measurements from the ACLS cohort involved in this analysis were previously
described in detail at the beginning of Chapter III. The following is an overview of the
variables used to investigate Hypothesis I.
Definition of Outcome
The outcome of interest was coronary heart disease (CHD). This event was
defined as the self-report of myocardial infarction or revascularization (including, bypass,
coronary balloon, angioplasty, or stent) at a return clinic visit or on a mail-back
questionnaire; or death due to CHD. The time to follow-up began at the baseline
examination and continued until CHD event or 1 July 2004. Deaths among study
participants were identified from the National Center for Health Statistic’s National
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Death Index. International Classification of Disease (ICD) codes: 410.0-414.0 and I20I25, were used to identify CHD as the primary cause of death. In accordance with FRS
follow-up time definition, the maximal follow up time was 12 years.
Predictor Variables
The covariates considered for analysis in the ACLS population mimicked the
variables included in the Framingham Risk Score. Age was defined as a continuous
variable. Hypertension (HTN) was defined through the categorization of systolic blood
pressure and diastolic blood pressure. Systolic and diastolic blood pressure were
categorized in to five levels. When an individual’s blood pressure fell in to different
categories for systolic and diastolic blood pressure, the higher category was chosen for
categorization. HTN definition was made without regard to a participant’s use for
antihypertensive medication. The definition of HTN parallels FRS’ definition that
utilized the measured systolic and diastolic blood pressure. 22,25
Total cholesterol and high density lipoprotein measures were grouped in to four
levels. : <200 mg/dL, 200-239 mg/dL, 240-279 mg/dL, and ≥ 280 mg/dL. High density
lipoproteins were categorized as: <35 mg/dL, 35-59 mg/dL, and ≥ 60 mg/dL. A 12-hour
fasting glucose >140 mg/dL classified an individual as having diabetes. Smoking status
was dichotomized as current or non-smoker. All categorizations and definitions were
analogous to FRS’ covariate groupings. 25
Statistical Analysis
Descriptive statistics were generated to compare the ACLS population to the
Framingham Heart Study population. The variables compared for the male populations of
each cohort were mean age, percentage within each category in HTN, total cholesterol,
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and HDL, percent diabetic, and percent whom are current smokers. Univariate Cox
Proportional Hazard models were performed for the outcome of interest and each
covariate to determine each characteristic’s prediction power. Survival analyses were
conducted to determine the 5 and 10 year CHD risk for the ACLS male population. The
full, age-adjusted survival model contained the outcome and all covariates. Statistical
tests were two sided and a p-value<0.05 signified statistical significance.
Predictive accuracy for both models, 10 and 20-year CHD risk, was determined
through the concordance-statistic (c statistic) associated with the receiver operating
characteristic (ROC) curve. The ROC curve estimates the concordance probability
between the observed and expected number of CHD events. The Hosmer-Lemeshow
statistic is used to assess calibration and is a chi-square test by sorting the sample by
estimated probability of success. 169 A limitation of the Hosmer-Lemeshow test is that it
is not recommended for sample sizes larger than 25,000. A sensitivity analysis was
performed following Paul et al’s (2013) recommendations and the ACLS sample
(n=34,557) was randomly divided in to two equal groups. The c-statistic from the
randomly divided sample cohorts and the full cohort were compared and no significant
statistical difference was found. All analyses were performed with the statistical software,
SAS version 9.3 (SAS).
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PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness
(CRF)
Purpose
This manuscript will address Hypothesis 2: the CRF variable will significantly
improve the Framingham Risk Score predictive ability of CHD events for men within the
ACLS population.
Study Design
Survival analysis and predictive modeling was performed using the ACLS
prospective cohort. Predictor variables were determined at baseline examination and each
participant and follow-up was conducted to ascertain information on the occurrence (or
non-occurrence) of a CHD event.
Study Population
The current analyses include men from the Cooper Clinic who completed a
baseline medical exam between 1970 and 2003. Participants between the ages of 30-74
were included in the analysis. Participants were excluded if they reported a history of
CHD, stroke, or cancer at baseline or did not have data available on systolic and diastolic
blood pressure, cigarette smoking, cholesterol levels, diabetes diagnosis, and
electrocardiogram. Participants were patients of the Cooper Clinic and asked to
participate in ACLS. Individuals were only included if they achieved ≥85% age-predicted
maximal heart rate at each visit. Participants were primarily from the middle to upper
socioeconomic group and had a median age of 44 years. The Institutional Review Board
at Cooper Clinic, Dallas, TX annually reviewed and approved ACLS’ protocol.
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Figure 3.2. Study flow for Paper 2 and Aerobic Center
Longitudinal Study (ACLS) inclusion criteria depicting
final sample size and coronary heart disease (CHD)
event frequency. Men with complete Framingham Risk
Score (FRS) data and body mass index (BMI) ≥ 18.5
kg/m2 were included in the analysis.

Measures
Measurements from the ACLS cohort involved in this analysis were previously
described in detail at the beginning of Chapter III. The following is an overview of the
variables used to investigate Hypothesis II.
Definition of Outcome
Coronary heart disease (CHD) was defined as the self-report of myocardial
infarction or revascularization (including, bypass, coronary balloon, angioplasty, or stent)
at a return clinic visit or on a mail-back questionnaire; or death due to CHD. The time to
follow-up began at the baseline examination and continued until CHD event or 1 July
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2004. Deaths among study participants were identified from the National Center for
Health Statistic’s National Death Index using ICD codes: I11 and I20-I25 that identify
CHD as the primary cause of death. In concordance with FRS follow-up time definition,
the maximal follow up time was 12 years. The risk of CHD was tested for a 5-year and
10-year follow up.
Predictor Variables
The measures utilized to test Hypothesis 2 are inclusive of the covariates
described to test Hypothesis 1, with the addition of cardiorespiratory fitness (CRF). In
brief, the objectively measured predictor variables included in the analysis were a five
level categorical variable for hypertension defined through systolic and diastolic blood
pressure, five levels of total cholesterol, high density lipoprotein categorized in five
different groups, diagnosis of diabetes defined as either yes or, and dichotomized current
smoking status. Age was included as a continuous variable. This version of FRS 25
incorporated categorical variables for age, hypertension, total cholesterol, HDL-C,
smoking, and diabetes to determine a point value that could be summed and interpreted
as an overall 10-year risk for CHD. The FRS was applied to every individual, and men
were stratified based on their level of 10-year CHD risk. A point summation ≤5 points
was classified as ‘low’ risk and a point summation >5 points was categorized as
‘moderate or high’ risk for CHD.
The main predictor variable of interest was cardiorespiratory fitness (CRF). A
maximal exercise test was performed to determine each participant’s CRF. The
technicians administered the Balke protocol for maximal exercise test while encouraging
the participant to reach the maximal capacity. Total treadmill time was used as an
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indicator of aerobic power. CRF is a gender-specific, age-adjusted Metabolic Equivalent
of Task (MET) value at the final grade and speed of the treadmill test. One MET is equal
to the amount of energy expended by an average person at rest. 168
Statistical Analysis
Descriptive statistics were generated to analyze the population’s representation
among the predictor variables. Univariate survival models were performed for CHD
event and each covariate to determine each characteristic’s prediction power. Men with
and without incident CHD were compared on mean age, mean fitness defined through
maximally achieved METs, proportion of men with low, moderate, or high CRF, the
average FRS point summation, proportion of men with ‘moderate or high’ 10-year CHD
risk, hypertension classification, cholesterol levels, diabetes diagnosis, and smoking
status. To determine each of the aforementioned covariate’s association with CHD
events, univariate survival analysis was performed. Cox Proportional Hazard Models,
adjusted for baseline examination year, also were fit to determine the association between
CRF and CHD events while controlling for 10-year CHD risk. To test for an interaction
between CRF and FRS, survival analysis was performed on a population stratified by
‘low’ and ‘moderate or high’ 10-year CHD risk, while adjusting for age and baseline
examination year. SAS® version 9.3 (SAS) was used to perform all analyses.
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PAPER 3: Determine the association between non-exercise estimated
Cardiorespiratory Fitness (e-CRF) and Coronary Heart Disease. Utilize e-CRF and
Framingham Risk Score (FRS) to predict the risk of CHD.
Purpose
This manuscript will address Hypothesis 3: the e-CRF will be significantly
protective against CHD. We also hypothesize that e-CRF and FRS will have a significant
association with CHD.
Study Design
Survival analysis and predictive modeling was performed using the ACLS
prospective cohort. Predictor variables were determined at baseline examination and each
participant and follow-up was conducted to ascertain information on the occurrence (or
non-occurrence) of a CHD event.
Study Population
Patients of the Cooper Clinic in Dallas, TX who consented to participation in the
ACLS cohort are considered for inclusion in the analysis. To be included in the following
analysis, participants had to complete their baseline examination between 1979 and 2002
and have at least one year of follow up. Only men were considered in this analysis
because of the low number of CHD events in women in the ACLS. Individuals were
between the age of 30-74 with a BMI higher than 18.5 kg/m2. Only individuals with
complete information on all the possible covariates were included in the analysis.
The majority of participants were Non-Hispanic, White, with a median age of 44
years. Most participants were well-educated and represented the middle to upper
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socioeconomic group. The Cooper Clinic’s Institutional Review Board annually reviewed
and approved ACLS’ protocol.

Figure 3.3. Study flow for Paper 3 and Aerobic Center
Longitudinal Study (ACLS) inclusion criteria depicting
final sample size and coronary heart disease (CHD)
event frequency. Men with complete Framingham Risk
Score (FRS) data and body mass index (BMI) ≥ 18.5
kg/m2 were included in the analysis.

Measures
Measurements from the ACLS cohort involved in this analysis were previously
described in detail at the beginning of Chapter III. The following is an overview of the
variables used to investigate Hypothesis III.
Definition of Outcome
Coronary heart disease (CHD) was the outcome of interest for the proceeding
analyses. CHD was recorded if there was a presence of self-reported myocardial
infarction or revascularization (including, bypass, coronary balloon, angioplasty, or
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stent), or death due to CHD. Follow up was measured at the baseline examination and
continued until occurrence of CHD event or 1 July 2004. Deaths among study
participants were identified from the National Center for Health Statistic’s National
Death Index through December 31, 2003. In concordance with FRS follow-up time
definition, the maximal follow up time was 12 years.
Predictor Variables
The variables considered in the age-adjusted reduced model for Hypothesis 3 are
estimated MET values for CRF, systolic and diastolic blood pressure classified as a five
level hypertension variable, objectively measured cholesterol levels: total cholesterol and
high density lipoprotein, diabetes diagnosis assessed through a 12-hour fasting glucose,
and a self-report current smoking status. A composite score was derived from FRS and
point values were tabulated for each participant based on Wilson et al’s study 113 and the
cohort was stratified based on their ‘low’ or ‘moderate or high’ 10-year CHD risk. A
point summation > 5 points was considered ‘moderate or high’ risk. A non-exercise
predictor variable of CRF based on the prediction modeling of Jurca et al (2005) 170 will
replace CRF that was measured by a maximal exercise test.
Estimated CRF (e-CRF) is a non-exercise estimation of CRF generated from a 6item, non-exercise, scale estimating CRF (e-CRF) 171 was recently developed and
incorporates age, body mass index (BMI), waist circumference, resting heart rate,
smoking status, and physical activity. Physical activity was captured through a medical
history questionnaire where participants reported their regular physical activity for the
past 3 months. 41,172 Physical activity was then dichotomized in to two levels: none or
low, and moderate or high physical activity. The accuracy of the developed algorithm
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was determine by computing the random intercept’s square root of the sum and the
residual variances. 171,173 Estimated CRF (e-CRF) was expressed in metabolic equivalent
of task (MET) units. METs were estimated using a 6-item questionnaire 170,174. The sexspecific questionnaire is composed of a participant’s age, BMI, waist circumference
(WC), resting heart rate (RHR), two-level physical activity (activity), and smoking status
(smoke). These variables are applied to Jackson et al’s algorithm 171 below.
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The estimated METs were categorized into three age-adjusted e-CRF tertiles: low,
middle, or high e-CRF. This classification is similar to previous e-CRF studies. 171

Statistical Analysis
Descriptive statistics were calculated for the total study population and stratified
by e-CRF. Chi-square tests were conducted to determine significant differences between
the e-CRF levels and each risk factor. Death rate per 10,000 person-years for follow-up
was calculated for e-CRF and 10-year CHD Risk. Crude Cox Proportional Hazard
Models, adjusting for baseline examination year, were generated to determine the
association between e-CRF and CHD, and the relationship between 10-year CHD risk
and CHD. A fully adjusted Cox Proportional Hazard Model was used to determine the
relationship between e-CRF, 10-year CHD risk and CHD. The effect of e-CRF on CHD
also was investigated on population subsets defined by age, smoking status, hypertension
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status, and diabetes diagnosis. To investigate if there was a significant interaction
between e-CRF and 10-year CHD risk, the male ACLS participants were stratified by
‘low’ or ‘moderate or high’ CHD risk and hazard ratios between e-CRF and CHD were
calculated. The receiver operating characteristic (ROC) curves were plotted to determine
if there was a significant improvement in the predictive accuracy of CHD by augmenting
the FRS point summation with e-CRF. The chi-square test determined if there was a
significant difference between the models. The Hosmer-Lemeshow statistics was used to
asses calibration and goodness of fit; the statistics compares the predictive and observed
events but is limited to sample sizes smaller than 10,000 observations. 169 To control for
this limitation, a random sample population was generated from the larger study
population to perform this goodness of fit test. SAS® version 9.3 was used to perform all
descriptive, survival, and predictive analyses.
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CHAPTER IV
Factors Related to Coronary Heart Disease Risk in Men: Validation of the
Framingham Risk Score1

1

Gander J, Sui X, Hazlett LJ, Cai B, Hébert JR, Blair SN. Accepted by Preventing
Chronic Disease. Reprinted here with permission of publisher, 06/24/2014.
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Abstract
Coronary heart disease (CHD) remains a leading cause of death in the United States. The
Framingham Risk Score (FRS) was developed to help clinicians in determining their
patients’ CHD risk. We hypothesize that the FRS will be significantly predictive of CHD
events in men within the Aerobics Center Longitudinal Study (ACLS) population.
Methods
The study included 34,557 men who attended the Cooper Clinic in Dallas, TX for a
baseline clinical exam between 1970 and 2003. CHD events included self-reported
myocardial infarction or revascularization, or death due to CHD. There were 587 CHD
events during the 12-year follow-up. Multivariable-adjusted hazard ratios generated from
ACLS analysis were compared to the FRS’ application to the Framingham Heart Study
(FHS).
Results
The ACLS cohort produced similar hazard ratios to the FHS. The adjusted Cox
proportional hazard model revealed men with total cholesterol of ≥280mg/dL were 2.21
(95% Confidence Interval (CI) 1.59, 3.09) times more likely to have a CHD event
compared to men with total cholesterol between 160-199mg/dL; men with diabetes were
1.63 (95% CI 1.35, 1.98) times more likely to experience a CHD event compared to men
without diabetes.
Conclusion
The FRS significantly predicts CHD events in the ACLS cohort. To the best of our
knowledge, this is the first report of a large, single-center cohort study to validate the
FRS using extensive laboratory and clinical measurements.
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Introduction
Coronary heart disease (CHD) remains one of the leading causes of death in the
United States, accounting for approximately 17% of the overall national health care
expenditures. 3 CHD is the accrual of plaque in the arteries of the heart 6 that supply the
blood for maintaining normal cardiac function. The accumulation of plaque narrows the
heart’s arteries and reduces blood flow to the heart muscle. The lack of oxygen-rich
blood to portions of the heart muscle leads to ischemia of myocardial tissues and
consequent alteration of heart function. CHD also can be caused by the deposition of fat
beneath the endothelium, reducing the elasticity of arteries. 6 This arterial damage has
been shown to be caused by an array of significant risk factors such as hypertension, 74
hypercholesterolemia, 14 diabetes, 16 and smoking. 11 However, because these risk factors
are modifiable through individual and population-level behavior change, medical
prevention through closely monitoring cholesterol, blood glucose, and other risk factors,
and treating any of these risk factors that are above acceptable ranges with medication
such as statins or insulin, many countries have experienced a decrease of CHD incidence
in the past 30 years. 8
Several risk scores have been developed to provide guidance to clinicians on their
patients’ risk for CHD. 18,23 The Framingham Risk Score (FRS) 23,25 is the CHD risk
score most widely utilized by clinicians across the globe. 24 The FRS originated from the
Framingham Heart Study (FHS), a relatively homogeneous cohort residing in
Framingham, Massachusetts, 23 and has been applied and validated in a variety of
different populations. 26,114 However, Kagan et al’s 26 study lacked complete congruency
with FRS methodology and other studies such as Lee et al’s 114 and Fried et al’s 175 had

80

relatively small sample sizes. A recent publication updated the 1998 FRS and developed
a new risk score that predicted an individual’s cardiovascular disease risk, instead of the
CHD outcome. 176 For the purposes of this study, we have chosen to investigate CHD
outcomes as they comprise the majority of CVD events. 177
The current research aims to expand on the recent validation studies 28 employing
the Aerobics Center Longitudinal Study (ACLS) cohort and the measured outcome of 10year risk for CHD. ACLS provides a larger cohort to validate FRS compared to FHS or
previous studies and FRS has yet to be applied to this cohort. This cohort includes
extensive measures of FRS components and CHD outcomes on more than 40,000
participants. 43 We hypothesize that the FRS will be significantly predictive of CHD
events for men within the ACLS population.

Methods
Study Population
ACLS is an observational longitudinal study whose members were patients of the
Cooper Clinic, Dallas, TX, where they received a preventive medical examination and
counseling on health behaviors during periodic visits. The Cooper Clinic serves anyone
who elects to come for an examination and patients come from all 50 states. During the
patients’ medical examination, they were informed of the ACLS, asked to participate,
and, if they agreed to participate, consented to follow-up surveillance. The ACLS
protocol was annually reviewed and approved by the Cooper Institute Institutional
Review Board.
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The participants were examined at least once during 1970 and 2003 at the Cooper
Clinic. The cohort consists mostly of individuals within the middle and upper
socioeconomic groups, with approximately 80% holding college degrees. 41 The mean
baseline age of the cohort was 42 years 34 and consisted mostly of men (75%) and nonHispanic Whites (>95%).
Although ACLS is not a representative sample of the entire US population, a
comparison of median values of specific physiological variables show similarity to
representative population data 164. A large number of women were enrolled in ACLS
(n=11,276), however, women were excluded from this analysis due to the small number
of CHD events (n=45) during the follow-up period. The following inclusion criteria were
applied to the ACLS cohort for the current study: 1) Age at baseline examination between
30-74 years; 2) Complete data for outcome and predictor variables; and 3) Free of CHD
diagnosis or cancer diagnosis at baseline. To control for any unmeasured confounders
that may have caused early drop-out, men with less than one year of follow-up were
excluded from the study’s cohort. Figure 1 shows the flow diagram of the study
participants.

Clinical Examination
Trained technicians followed standardized protocols while conducting each
measurement. The baseline clinical exam included a personal and family medical history,
anthropometric measurements, a 12-hour fasting blood chemistry including glucose and
cholesterol measurements, ECG, blood pressure assessment, and a maximal exercise test.
112,164
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Measures
Definition of Outcome
CHD was the primary endpoint being investigated. CHD was defined as the selfreport of myocardial infarction or revascularization (including, bypass, coronary balloon,
angioplasty, or stent), or death due to CHD. Participants reported their history of
infarction or revascularization and incident date through a mail-back questionnaire
administered in 1982, 1986, 1990, 1995, 1999, and 2004. Deaths among study
participants were identified from the National Center for Health Statistic’s National
Death Index. International Classification of Disease (ICD), Ninth and Tenth Revisions,
codes: 410.0-414.0 and I20-I25, respectively, were used to identify CHD as the primary
cause of death. According to FRS’ follow-up time definition, the maximal follow up time
was 12 years. The 12-year follow up was used in the regression and survival analysis and
then adapted to provide a 10-year CHD incidence estimates.

Predictor Variables
The covariates considered for analyses in the ACLS population mimicked the
variables included in the recently-updated Framingham Risk Score. 25 Hypertension
(HTN) was divided into four categories according to systolic blood pressure and diastolic
blood pressure. Systolic blood pressure was categorized into four levels: <130 mm Hg,
130-139 mm Hg, 140-159 mm Hg, or ≥160 mm Hg. Diastolic blood pressure was
categorized into four levels: <85 mm Hg, 85-89 mm Hg, 90-99 mm Hg, and ≥ 100 mm
Hg. When an individual’s blood pressure fell into different categories for systolic and
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diastolic blood pressure, the higher category was chosen for categorization. For example,
if a participant’s blood pressure was 130/80 (SBP/DBP), the corresponding categories for
systolic blood pressure would be 2, and the diastolic blood pressure category would be 1.
To determine the HTN category, the higher classification would be chosen and the HTN
categorization would be 2 in this example. HTN definition was made without regard to a
participant’s use of antihypertensive medications. The definition of HTN parallels FRS’
definition. 25
Total cholesterol was grouped into four levels: <200 mg/dL, 200-239 mg/dL, 240279 mg/dL, and ≥ 280 mg/dL. High density lipoprotein was categorized as: <35 mg/dL,
35-59 mg/dL, and ≥ 60 mg/dL. A 12-hour fasting glucose >140 mg/dL classified an
individual as having diabetes. Smoking status was dichotomized as current or nonsmoker. All categorizations and definitions were analogous to FRS’ covariate groupings.
25

Statistical Analysis
Descriptive statistics were generated to compare the ACLS population to the
Framingham Heart Study population. Males in each cohort were compared on mean age,
percentage within each category in HTN, total cholesterol, and HDL, percent diabetic,
and percent of current smokers. Univariate Cox Proportional Hazard models were
performed for the CHD events and each covariate to determine each characteristic’s
predictive power. Cox Survival analyses were conducted to determine the 10-year CHD
risk for the ACLS male population. The fully adjusted Cox Proportional Hazard model
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included age, blood pressure, total cholesterol, high density lipoprotein cholesterol,
diabetes diagnosis, and smoking status.
Predictive accuracy was determined through the concordance-statistic (c-statistic)
associated with the receiver operating characteristic (ROC) curve. The ROC curve
measures the discrimination power of these diagnostic markers for the CHD outcome.
The Hosmer-Lemeshow statistic is used to assess calibration and is a chi-square test
calculated by sorting the sample by estimated probability of success 169. The higher the cstatistic the better the prediction. A limitation of the Hosmer-Lemeshow test is that it is
not recommended for sample sizes larger than 25,000. A sensitivity analysis was
performed following Paul et al’s 169 recommendations and the ACLS sample (n=34,557)
and a smaller 10,000 sample cohort was randomly selected. To satisfy this limitation, the
Hosmer-Lemeshow test was performed on a randomly selected cohort (n=10,000) and a
p-value>.05 represent no significant difference between predicted and observed events.
All analyses were performed using SAS® version 9.3 (SAS).

Results
During a 12-year follow- period (284,572 person-years of exposure), 587 men had
a CHD event. The incidence rate was 20 per 10,000 person-years. The ACLS cohort had
approximately 32,000 more participants (Table 4.1) compared to the Framingham Heart
Study (FHS) and were, on average, younger (p<0.0001). FHS had a higher proportion of
diabetics (5.0%) and smokers (40.0%) compared to the ACLS cohort of 1.5% and 17.0%
respectively (p<0.0001) (Table 4.2).
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When the ACLS cohort is stratified by CHD status, men who experienced a CHD
event during the 12-year follow-up period were significantly different on all predictor
variables; i.e. they were older, had higher blood pressure and were in the upper two
categories for high-density lipoprotein cholesterol. Among those men who experienced
CHD during follow-up, 4.6% were diabetic and 23.3% were smokers compared to 1.47%
(p<0.001) and 16.8% (p<0.001) who did not experience CHD, respectively (Table 4.3).
Table 4.3 displays the unadjusted and fully adjusted survival models. The
covariates that were based on the FRS were all significant when applied to the men in
ACLS. The hazard ratios reported from FHS by D’Agostino et al (2001)28 are similar to
the ACLS fully adjusted hazard ratios. The fully adjusted HRs show men with Stage I
HTN (HR=1.41; 95%CI 1.16, 1.72) have significantly higher risk of CHD compared to
men with optimal or normal blood pressure. Men with total cholesterol of ≥280mg/dL
were more than twice (HR=2.21; 95% CI 1.59, 3.09) as likely to have a CHD event
compared to men with total cholesterol between 160-199mg/dL Men with diabetes were
1.82 (95% CI 1.23, 2.70) times more likely to experience a CHD event compared to men
without diabetes. Smokers also experienced a significantly higher risk (HR=1.63; 95%CI
1.35, 1.98) for CHD compared to past/nonsmokers during the 12-year follow-up.
Figure 4.2 portrays the receiver operating characteristic (ROC) curve. The cstatistic (Area Under the Curve) obtained from the ROC curve was 0.77 (95% CI 0.7523,
0.7871). The Hosmer-Lemeshow test reported there was not a significant lack of fit for
the model (p-value 0.88) and we failed to reject the null hypothesis that states there is no
significant difference between the predicted and observed values of the outcome variable.

86

Discussion
The FRS significantly predicts CHD events occurring during a 12-year follow-up
in the Aerobics Center Longitudinal Study, which was a much larger study than the
original Framingham Heart Study. In addition to our main finding, age, blood pressure,
total cholesterol, high density lipoprotein cholesterol, diabetes diagnosis, and smoking
status were associated with CHD events. The relative risks were congruent with the those
reported from the FHS 28 and previous literature. 26,114
Elevated blood pressure creates more strain for the heart which can cause stiffness
of the muscle 6 or create microscopic tears in the walls that may develop in to scar tissue
6

. Myocardial ischemia is common in patients with hypertension 16,74 and reports from the

FHS showed that hypertension was the primary cause of congestive heart failure in 35%
of cases. 77 Diabetic men are also at increased risk for CHD 83 and additional research
shows that individuals with both diabetes and .hypertension have a higher incidence of
heart disease compared to people with diabetes or hypertension alone. 16
Doyle et al published one of the first studies examining the association between
smoking and CHD 71 in two prospective studies: The FHS and the Albany, New York
Civil Servant study, with a combined study population of over 1,800 men without CHD
71

. The study concluded that men with elevated systolic blood pressure and total

cholesterol who smoked were at a 1.8 (p<0.05) times higher risk of mortality compared to
men with elevated systolic blood pressure and total cholesterol who did not smoke. 71 Our
findings are also in line with The Physicians’ Health Study that reported significant
effects of HDL and total cholesterol on CHD. 28
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Researchers have previously investigated FRS’ predictability in various
populations. The Honolulu Heart Study was initiated in 1965 with the overall goal of
standardizing cardiovascular examination. 26 The cohort is comprised of Japanese men
born between 1900 and 1919 and updated with their World War II Selective Service
Files; approximately 8,000 individuals free of CHD at study initiation, with a baseline
examination constituted the final population26. Cigarette smoking, cholesterol levels,
blood pressure, sum of skinfolds, and uric acid levels were significant predictors of CHD;
however glucose intolerance showed no significant relationship. The lack of congruency
in the significant results between the Honolulu Heart Study, FHS, and ACLS may be due
to the Honolulu Heart Study population being at low risk of CHD (i.e. CHD incidence
observed in the Honolulu Study was about half that of the FHS).
To the best of our knowledge, this is the first large, single-center, prospective
cohort to validate the FRS with the same level of precision as that in the FHS. The
present study expands on previous research through the improvement of internal validity
by utilizing objectively measured clinical data.
Similar to FHS, a potential limitation of the ACLS cohort is the homogeneity of
the study population’s sociodemographic factors. This limitation was explored through
comparison analysis between ACLS and two large population-based cohorts and found
that ACLS’ results were similar to the results of the Lipid Research Clinics Prevalence
Survey and the Canada Fitness Survey. 165 It should be noted that ACLS’ homogeneity
may be a strength through the improvement of internal validity by controlling for
potential demographic confounders such as education, socioeconomic status, and
race/ethnicity; however, generalizations must be made cautiously and future research
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should be conducted in more diverse populations. Unlike the FHS, stage II-IV
hypertension was not significantly associated with CHD and may be due to the limitation
in the small proportion (4.93%) of ACLS’ cohort was categorized in to this group.

Conclusion
Although CHD remains one of the leading causes of death in the United States,
the prevalence of CHD has decreased since 2004;4 a reduction that can be largely
attributed to better medical treatment and improvement in CHD risk profiles. The FRS
was developed to assist clinicians in estimating their patients’ absolute risk for CHD. 28
This study further evaluates FRS’ performance in the larger ACLS cohort, and strictly
followed the FHS methodology which does not control for other CHD risk factors such
self-rated health, 141 family history 95 of CHD, and cardiorespiratory fitness. 43 Future
research should focus on the expansion of the FRS to include other modifiable risk
factors. Community interventions and education programs should continue to target these
CHD risk factors to further the prevention of heart disease.
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Table 4.1. Comparison of Demographic Characteristics
Between men free of coronary vascular disease at baseline
the Framingham Heart Study (FHS) and the Aerobics
Center Longitudinal Study (ACLS)a.
Study Comparisonb
RISK FACTOR
FHSd
ACLS
n=2,439
n=34,557
Age, range (years)
30-74
30-74
Mean age, y
48.30
44.82
Blood Pressure, (mm HG)
Optimal and Normal
44.00
59.85
(S<130, D<85)
High Normal
20.00
16.24
(S<140, D<90)
Stage I HTN
23.00
18.98
(S<160, D<100)
Stage II-IV HTN
13.00
4.93
(S≥160, D≥100)
Total Cholesterol (mg/dL)
<160
7.00
9.34
160-199
31.00
34.36
200-239
39.00
36.67
240-279
17.00
15.10
≥280
6.00
4.53
HDL-C (mg/dL)
<35
19.00
16.24
35-59
70.00
70.97
≥60
11.00
12.79
Diabetes
5.00
1.52
Current Smoking
40.00
16.95
Abbreviations: CI; confidence interval; HTN,
hypertension; HDL-C, high density lipoprotein
cholesterol
a
The numbers displayed are percentages unless
otherwise stated
b
Independent t-test was used to determine statistically
significant difference of age between FHS and ACLS;
Proportion test calculated the statistical difference for
each level of blood pressure, total cholesterol, HDL,
diabetes, and current smoking between FHS and ACLS.
All proportion tests were significant with a pvalue<0.001.
c
FHS, Framingham Risk Score descriptive statistics
referenced from D'Agostina et al (17)
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Table 4.2. Comparison in Demographic Characteristics Between Men With
and Without a Coronary Heart Disease (CHD) Event in the Aerobic Center
Longitudinal Study (ACLS)a.
CHD Event Comparison within
ACLSb
RISK FACTOR

Median Follow-up Time (IQR)
Age, range (years)
Mean age, y
Blood Pressure, (mm HG)
Optimal and Normal
(S<130, D<85)
High Normal
(S<140, D<90)
Stage I HTN
(S<160, D<100)
Stage II-IV HTN
(S≥160, D≥100)
Total Cholesterol (mg/dL)
<160
160-199
200-239
240-279
≥280
HDL-C (mg/dL)
<35
35-59
≥60
Diabetes
Current Smoking

No CHD
n=33,970
10.94
(3.82, 12.00)
30-74
44.70

With CHD
n=587
5.66
(2.94, 8.93)
30-73
51.91

60.06

47.53

16.18

19.76

18.85

26.41

4.90

6.30

9.44
34.62
36.60
14.88
4.46

3.92
19.59
40.37
27.60
8.52

16.08
71.05
12.88
1.47
16.84

25.55
66.44
8.01
4.60
23.34

Abbreviations: HTN, hypertension; HDL-C, high density
lipoprotein cholesterol
a
The numbers displayed are percentages unless otherwise stated
b
Chi-square test was performed to calculate statistical difference
between the group with and without CHD. All comparisons were
significant with p-value<0.05
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Table 4.3. Hazard Ratios for coronary heart disease (CHD) Events for Framingham Heart Study
(FHS) Cohort Compared to Aerobics Center Longitudinal Study (ACLS) Cohort
ACLS 12y Follow-up
FHSa
Unadjusted
Fully Adjustedb
HR
95% CI
HR
95% CI
HR
95% CI
1.05
1.04 1.06
1.09
1.08 1.10
1.09
1.08 1.10
Age (years)
Blood Pressure, mm HG
Optimal and Normal
1.00
Referent
1.00
Referent
1.00
Referent
(S<130, D<85)
High Normal
1.31
0.98 1.76
1.66
1.33 2.06
1.33
1.07 1.66
(S<140, D<90)
Stage I HTN
1.67
1.28 2.18
1.95
1.60 2.38
1.41
1.16 1.72
(S<160, D<100)
Stage II-IV HTN
1.84
1.37 2.06
1.94
1.37 2.73
1.23
0.87 1.74
(S≥160, D≥100)
Total Cholesterol (mg/dL)
<160
0.69
0.31 1.52
0.77
0.49 1.21
0.82
0.52 1.28
160-199
1.00
Referent
1.00
Referent
1.00
Referent
200-239
1.77
1.25 2.50
1.85
1.48 2.31
1.59
1.27 1.99
240-279
2.10
1.43 3.10
2.90
2.28 3.68
2.37
1.86 3.01
≥280
2.29
1.39 3.76
2.74
1.97 3.83
2.21
1.59 3.09
HDL-C (mg/dL)
<35
1.47
1.16 1.86
1.59
1.32 1.92
1.60
1.32 1.94
35-59
1.00
Referent
1.00
Referent
1.00
Referent
≥60
0.56
0.37 0.83
0.66
0.49 0.90
0.60
0.44 0.81
Diabetes
1.50
1.06 2.13
3.45
2.34 5.07
1.82
1.23 2.70
Smoking Status
1.68
1.37 2.06
1.60
1.32 1.93
1.63
1.35 1.98
Abbreviations: CI; confidence interval; HR, Hazard Ratio; HTN, hypertension; HDL-C, high density
lipoprotein cholesterol

a

Framingham Heart Study hazard ratios from Wilson et al 1998 (10)
Fully adjusted model included age, blood pressure, total cholesterol, high density lipoprotein levels, diabetes
diagnosis, and smoking status
b
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Figure 4.1. Study flow and Aerobic Center Longitudinal Study
(ACLS) inclusion criteria depicting final sample size and
coronary heart disease (CHD) event frequency. Men with
complete Framingham Risk Score (FRS) data and body mass
index (BMI) ≥ 18.5 kg/m2 were included in the analysis.
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Figure 4.2.Receiver Operating Characteristic Curve representing the
predictive ability of the Framingham Risk Score (FRS) applied to the
ACLS cohort with a 12 year follow-up. The Hosmer-Lemeshow cstatistic is represent by the Area Under the Curve (c=0.7697, 95%
Confidence Interval 0.7523, 0.7871)
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CHAPTER V
Incorporation of Cardiorespiratory Fitness in the Framingham Risk Score in
Asymptomatic Men1

1

Gander J, Sui X, Hébert JR, Hazlett LJ, Cai B, Lavie CJ, Blair SN. Submitted to
Circulation, 06/12/2014.
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Abstract
Background
The Framingham Risk Score (FRS) includes a limited set of risk factors and does
not include cardiorespiratory fitness (CRF), which has been shown to have a strong
protective effect on coronary heart disease (CHD). We aim to examine the association of
CRF on 10-year risk of CHD while controlling for individuals’ FRS.
Methods and Results
The study included 29,854 men from the Aerobics Center Longitudinal Study
(ACLS) who received a baseline examination from 1979 to 2002. CHD events included
self-reported myocardial infarction or revascularization, or CHD death. Multivariable
survival analysis investigated the association between CRF, FRS, and CHD. CRF was
analyzed as both a continuous and categorical variable. The population was stratified by
‘low’ and ‘moderate or high’ risk for CHD to test for interaction between CRF and FRS.
Men with incident CHD were older (mean age = 51.6 years), had an average
maximally achieved fitness of 10.9 metabolic equivalent of task (METs), and were more
likely to have ‘moderate or high’ 10-year CHD risk, compared to men without incident
CHD (p-value<0.001). CRF, defined as maximal METs, showed a 20% lower risk of
CHD (HR=0.80, 95% CI 0.77, 0.83) for each 1 unit MET increase. Men within the ‘low’
10-year CHD risk strata and high (HR=0.62, 95% CI 0.45, 0.84) CRF had a lower CHD
risk compared with men in the same strata, but with low CRF (p-value <0.001).
Conclusion
Clinicians should emphasize the promotion of physical activity to improve CRF to reduce
CHD risk, even in patients with otherwise low CHD risk.
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Introduction
The American Heart Association stated one of its 2020 Impact Goals was to reduce the
deaths from cardiovascular disease (CVD) by 20%;4 coronary heart disease (CHD)
comprised the majority of CVD deaths in 2006 and 2007.177 CHD is classified as plaque
accumulation in the arteries of the heart, decreasing the supply of oxygen-rich blood.177
Several risk factors have been shown to significantly predict CHD, including: smoking,11
diabetes, 16 hypertension,74 and hypercholesterolemia.14
CHD risk equations, such as the Framingham Risk Score (FRS), have been developed
and employed to account for these and other risk factors .23 The FRS provides a sexspecific, age-adjusted risk score that accounts for systolic and diastolic blood pressure,
total cholesterol, high-density lipoprotein cholesterol (HDL-C), diabetes diagnosis, and
smoking status.25 Previous studies 29,30,104 have modified the FRS to include additional
risk factors. Tzoulaki et al 104 conducted a meta-analysis on 63 studies and examined how
each study modified the FRS, including the addition of C-reactive protein,29 deletion of
diabetes diagnosis,30 and alterations to blood pressure definitions.178
None of these modifications involved the addition of cardiorespiratory fitness (CRF), a
characteristic that has shown significant protective effects for all-cause mortality, 43,136
cancer-related mortality,139 diabetes incidence,34 and CHD incidence 47 and
mortality.25,45,46 Barlow et al 163 showed that a 1-MET increase in CRF resulted in an 18%
decrease in CVD mortality over a 30-year follow-up period in “low-risk” adults, as
defined by the FRS. However, this result reflects control for additional factors besides
CRF, such as body mass index (BMI) and early family history of CHD, which are not
included in the FRS.
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The aim of this study is to examine the association of CRF on 10-year risk of CHD while
controlling for an individual’s FRS. Our secondary aim is to investigate if the relationship
between CRF and 10-year risk of CHD differs in ‘low risk’ males.

Methods
Study Population
The Aerobics Center Longitudinal Study (ACLS) is a prospective cohort study involving
a large group of men and women. The participants were patients of the Cooper Clinic,
where they received a preventive medical examination and counseling on health
behaviors during periodic visits. The participants were examined at least once from 1979
to 2002 at the Cooper Clinic, Dallas, Texas. The protocol for ACLS was reviewed
annually and approved by the Cooper Institute Institutional Review Board. Women were
excluded from these analyses due to a small number of CHD events (n=45). Men were
included based on the following criteria: 1) Age at baseline examination between 30-74
years; 2) Complete data for outcome and predictor variables; and 3) Free of CVD or
cancer diagnosis at baseline. A flow diagram of the study population is depicted in Figure
5.1.
Clinical Examination
The baseline, clinical exam included an ECG, a 12-hour fasting blood chemistry analyses
including cholesterol and glucose measurements, blood pressure assessment, and a
maximal exercise test.112,164,166 A standardized questionnaire was used to assess smoking
status.
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Measures
Definition of Outcomes
CHD was defined through either self-report of revascularization (including, bypass,
coronary balloon, angioplasty, or stent) or myocardial infarction (MI), or CHD specific
mortality. A mail-back questionnaire was administered in 1982, 1986, 1990, 1995, 1999,
and 2004 in which participants were asked to report their history of revascularization or
MI along with the incident date. The National Center for Health Statistic’s National
Death Index was used to identify CHD deaths in the ACLS cohort; International
Classification of Disease (Ninth and Tenth Revisions) codes 410.0-414.0 were used to
determine CHD as the primary cause of death. In accordance with FRS’s follow-up time
definition, the maximal follow-up time for the ACLS study population was 12 years.

Application of Framingham Risk Score
FRS was derived from the Framingham Heart Study, which is an ongoing observational
study initiated in 1948 and primarily recruits residents of Framingham, Massachusetts.23
In a study published in 1998,25 the main outcome was a CHD event defined as a MI,
coronary insufficiency, or CHD death. This version of FRS25 incorporated categorical
variables for age, hypertension, total cholesterol, HDL-C, smoking, and diabetes to
determine a point value that could be summed and interpreted as an overall 10-year risk
for CHD. The FRS was applied to every individual, and men were stratified based on
their level of 10-year CHD risk. A point summation ≤5 points was classified as ‘low’ risk
and a point summation >5 points was categorized as ‘moderate or high’ risk for CHD.
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Cardiorespiratory Fitness
The Balke maximal exercise treadmill test 167 was used to determine CRF, which was
analyzed as a continuous and categorical variable. The continuous variable was the
maximally achieved metabolic equivalent of task (MET). The following regression
formula was employed to convert maximal treadmill time to METs :48
(

)

Treadmill time converted to METs is analogous to peak VO2.121
The categorical definition of CRF was based on a participant’s age-specific treadmill
time from the entire ACLS cohort and consisted of three levels: “low (least fit 20%)”,
“moderate (next fit 40%)”, and “high (most fit 40%)”.

Statistical Analysis
Descriptive statistics were computed for the total ACLS male population and stratified by
incidence of CHD. Men with and without incident CHD were compared on mean age,
mean fitness defined through maximally achieved METs, proportion of men with low,
moderate, or high CRF, the average FRS point summation, proportion of men with
‘moderate or high’ 10-year CHD risk, hypertension classification, cholesterol levels,
diabetes diagnosis, and smoking status. To determine each of the aforementioned
covariate’s association with CHD events, univariate survival analysis was performed.
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Cox Proportional Hazard Models, adjusted for baseline examination year, also were fit to
determine the association between CRF and CHD events while controlling for 10-year
CHD risk. To test for an interaction between CRF and FRS, survival analysis was
performed on a population stratified by ‘low’ and ‘moderate or high’ 10-year CHD risk,
while adjusting for age and baseline examination year. SAS® version 9.3 (SAS) was used
to perform all analyses.

Results
During a 12-year follow-up period (248,890 person-years of exposure), there were 499
incident CHD events. This ACLS cohort used the FRS on approximately 30,000 men
(Table 1). At baseline, the males in the overall ACLS cohort had an average age of 44.7
years, 60.6% had either optimal or normal blood pressure, 4.7% had stage II-IV
hypertension, 1.4% had diabetes, and 16. 6% reported being current smokers. Men with
incident CHD were older, had higher prevalence of stage I hypertension, a lower HDL-C
<35 mg/dL, a lower mean fitness, and were more likely to have ‘moderate or high’ 10year CHD risk, compared to men without incident CHD (p-value <0.0001 for all stated
comparisons).
Table 2 reports the univariate analyses between the risk factors that comprise the FRS
and the risk for CHD. Men with optimal blood pressure were 33% less likely to
experience a CHD event compared to men with normal blood pressure (HR=0.67, 95%
CI 0.52, 0.87), while men with stage I hypertension were at a significantly higher risk
(HR=1.55 95% CI 1.23, 1.97) for CHD. Men with HDL-C ≥60 mg/dL were at a
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significantly lower risk for CHD compared to men with HDL-C 45-49 mg/dL. Men
diagnosed with diabetes and current smokers also were at a significantly higher risk for
CHD compared to non-diabetics and non-smokers. For every FRS point increase, the
relative risk for a CHD event increased 36% (HR=1.36 95% CI 1.32, 1.40). Similarly,
men with a ‘moderate or high’ 10-year CHD risk had an almost 6-fold (HR=5.66 95% CI
4.25, 7.55) higher risk for CHD compared to men with a ‘low’ 10-year CHD risk. A
univariate analysis showed an inverse association between CRF and CHD. CRF, defined
as maximal METs showed a 20% lower CHD risk (HR=0.80, 95% CI 0.77, 0.83) for
each 1 MET increase. CRF also was categorized into low, moderate, and high and men
with high CRF had 33% (HR=0.67, 95% CI 0.51, 0.88) lower risk for CHD compared
with men who had low CRF (Table 3). Table 3 also reports the various survival models
fit to test the association between FRS point, CRF, and risk of CHD. Model four reports
the maximal METs protective effect on CHD (HR=0.82) while controlling for ‘moderate
or higher’ 10-year CHD risk. Model 5 evaluates a similar association, but defines CRF as
a categorical variable and shows that men with high CRF have 26% lower CHD risk
while controlling for ‘moderate or high’ 10-year CHD risk.
Figure 2 shows the association between CRF, FRS, and risk of CHD through
stratification of the population by low and ‘moderate or high’ 10-year CHD risk.
Compared with men in the same strata with low CRF there was a significant inverse trend
among men within the ‘low’10-year CHD risk strata; Men with moderate (HR=0.92 95%
CI 0.68, 1.25) and high (HR=0.62, 95% CI 0.45, 0.84) CRF had a lower probability of
experiencing CHD (Ptrend <0.001). These associations were similar for men with
‘moderate or high’ 10-year CHD risk, although not
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(Ptrend =0.22).

Discussion
Both FRS and CRF were strong independent predictors of CHD. CRF had a significant
protective effect on CHD in men, after controlling for 10-year CHD risk based on the
FRS point summation. When men were stratified by ‘low’ and ‘moderate or high’ 10year CHD risk, CRF’s protective effect became more apparent, with a significant inverse
trend in low-risk adults. To our knowledge, this is the first study to investigate the
association between CRF and CHD in males with ‘low’ and ‘moderate or high’ 10-year
CHD risk.
The FRS is comprised of CHD risk factors such as hypertension, cholesterol levels,
diabetes diagnosis, and smoking.25 Various versions 22,25,26,176 that have included these
risk factors repeatedly have shown the predictive power of the FRS. 179 Myocardial
ischemia is common in patients with hypertension;16,74,75 although a recent study reported
a 1.4 mm Hg decrease in mean systolic blood pressure from 1994 to 2005 that could be
associated with a 20% reduction in CHD deaths.9 A diabetes diagnosis also previously
has been shown to significantly increase a person’s risk for CHD.83,84 Diabetes can cause
impairment in the cardiac muscle that may lead to cardiomyopathy, congestive heart
failure, or ischemic heart disease and can increase the 5-year mortality rate after a
myocardial infarction.16 Doyle et al published one of the first studies examining the
association between smoking and CHD.71 That study concluded that while problems with
blood pressure and cholesterol were absent, participants who reported being smokers
were at a significantly higher risk for CHD mortality compared to nonsmokers.71
Our finding that CRF has a significant protective effect on CHD is similar to findings
previously reported in the literature.34,43,46,87 Ekelund et al investigated the relationship
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between CRF and CHD in asymptomatic men and found during a nine year follow-up the
more fit men had the least CHD risk compared to the fourth quartile.45 Lee et al built on
these findings by analyzing CRF’s association with CVD while controlling for body
composition. That study reported that lean, unfit men had three times higher risk of dying
from CVD (RR=3.16, 95% CI 1.12, 8.92) compared to lean, fit men.46 Improved CRF
may reduce CHD risk through improved muscle mass 152,153 and enhancement in arterial
oxygen content.180 Research has shown that CRF can increase the double-product
threshold for ischemic ST-segment depression,154,155 a decrease in the magnitude of ST
depression, and a diminished maximal ST depression.154 CRF also may have a positive
effect on coagulation 156,157 and may protect against thrombosis.45

Our findings regarding the association between CRF, FRS, and risk for CHD are
consistent with recent findings. Barlow et al 163 investigated the association of CRF and
CVD mortality in men and women that were at low risk for CHD events. The study
concluded that a 1-MET increase in CRF resulted in an 18% decrease in CVD mortality
during a 30 year follow up period.163 Gupta et al 50 utilized the ACLS cohort with data
ranging from 1970 through 2006 and employed a traditional CHD risk factor model that
adjusts for age, systolic blood pressure, diabetes, total cholesterol, and smoking status
and reported that CRF augmented CHD risk factor model correctly reclassified
participants with CHD death based on their 10-year risk,50 compared to the traditional
FRS model.
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The current study builds on the aforementioned research by applying the FRS to a large,
single-center, longitudinal cohort with the same level of precision as the Framingham
Heart Study that generated the FRS. The previous studies either modified the outcome of
interest or the predictor variables included in the risk score. The American College of
Cardiology and the American Heart Association recently developed the Pooled Cohort
Equation for estimating artherosclerotic cardiovascular disease (ASCVD) 181 that
encompassess similar risk factors as FRS but offers risk estimates for myocardial
infarction, CHD death, stroke, and stroke death. This project decided to focus on
prevoiusly defined CHD that includes angioplasty and revascularization while excluding
stroke and stroke death. Future research should investigate the potential effect the Pooled
Cohort Equation may have on ASCVD with the addition of CRF.
To the best of our knowledge, this is the first prospective cohort to investigate CRF’s
associations with 10-year risk of CHD while controlling for the FRS 25 in its entirety. A
possible limitation to the current study is the homogeneity of the ACLS population. At
the time of enrollment, ACLS consisted of mostly men, mean age 42 years , and was
predominantly non-Hispanic Whites (>95%). However, a comparison study between
ACLS and two large population-based cohorts found ACLS’s results were similar to that
of those cohorts.165 It also should be noted that ACLS’ homogeneity improves internal
validity by controlling potential confounders such as socioeconomic status and education,
although generalizations from this study should be made cautiously.
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Conclusion
Our study found that CRF and FRS are both significant predictors of CHD events.
Moderate and high fit men have lower risk for CHD compared to men with low CRF; this
association remains significant when the population was stratified into ‘low’ and
‘moderate or high’ risk for CHD. It may be advantageous for clinicians to evaluate a
patient’s CRF to provide a more accurate assessment of the 10-year risk for CHD. CRF is
a modifiable predictor of CHD and improved CRF may lead to an improvement in the
FRS and 10-year CHD risk, as well as an improvement in the ability to predict long-term
CHD risk. Clinicians should vigorously promote exercise therapy and increases in
physical activity to their patients in efforts to increase CRF in the long-term prevention of
CHD.182,183 Researchers should consider developing a randomized clinical trial to
determine the effect that CRF changes may have on an individual’s FRS overall, the
individual components of the risk score, and ultimately, the effect on 10-year risk for
CHD.
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Table 5.1. Comparison of demographic characteristics between men
(n=29,854) with incident coronary heart disease (CHD) and no incident
CHD, from the Aerobics Center Longitudinal Study (ACLS) prospective
cohort
No
Total
Incident
incident
RISK FACTOR
Population
CHD
CHD
p-value*
n=29,854
n=499
n=29,355
30-74
31-73
30-74
Age, range (years)
44.72
51.57
44.60
<0.0001
Mean Age, y
Mean Fitness,
maximally achieved
11.95
10.92
11.97
<0.0001
MET
Cardiorespiratory
Fitness
11.58
13.43
11.54
0.19
Low
38.45
43.29
38.37
0.03
Moderate
49.97
43.29
50.09
0.0029
High
3.51
6.15
3.47
<0.0001
Mean FRS, points
‘Moderate or High’
2.05
10.42
1.91
<0.0001
10year CHD risk
Blood Pressure, mm HG
Optimal
28.82
19.44
28.98
<0.0001
(S<120, D<80)
Normal
31.82
30.26
31.85
0.45
(S<130, D<85)
High Normal
15.97
19.64
15.91
0.02
(S<140, D<90)
Stage I HTN
18.72
25.45
18.61
<0.0001
(S<160, D<100)
Stage II-IV HTN
4.67
5.21
4.66
0.56
(S≥160, D≥100)
Total Cholesterol,
mg/dL
<160

9.15

3.81

9.25

<0.0001

160-169
200-239
240-279
≥280

34.11
36.90
15.30
4.54

19.24
40.48
27.25
9.22

34.36
36.84
15.10
4.46

<0.0001
0.09
<0.0001
<0.0001

<35
35-44

15.60
34.13

25.25
38.68

15.43
34.05

<0.0001
0.03

HDL-C, mg/dL
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45-49
50-59
≥60

15.58
13.03
15.62
0.11
21.42
15.83
21.52
0.0021
13.28
7.21
13.38
<0.0001
Diabetes
1.39
4.41
1.34
<0.0001
Current Smoking
16.56
21.84
16.47
0.001
Abbreviations: CHD, coronary heart disease; FRS, Framingham Risk Score;
HDL-C, high density lipoprotein- cholesterol; HR, hazard ratio; MET, metabolic
equivalent of task
*Student t-test was used to calculate the difference between incident CHD and no
incident CHD for age, mean fitness, and mean Framingham Risk Score points.
Chi-square test was performed to determine statistical significant difference for
remaining categorical variables.
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Table 5.2. Univariate survival analyses between the Framingham Risk
Score (FRS) risk factors and 10-year risk for coronary heart disease
(CHD)
Model One, Univariate
HR
95% CI

RISK FACTOR

1.09

1.08

1.10

0.67

0.52

0.87

1.00

--

--

1.36

1.06

1.76

1.55

1.23

1.97

1.34

0.89

2.04

<160
160-169
200-239
240-279
≥280

0.77
1.00
1.87
2.89
3.03

0.47
-1.47
2.22
2.14

1.26
-2.38
3.75
4.31

<35

1.82

1.35

2.46

35-44
45-49
50-59
≥60

1.33
1.00
0.89
0.64
3.54
1.51

1.01
-0.64
0.43
2.31
1.22

1.76
-1.23
0.96
5.42
1.87

Age
Blood Pressure, mm HG
Optimal
(SBP<120, DBP<80)
Normal
(SBP <130, D<85)
High Normal
(SBP <140, DBP<90)
Stage I HTN
(SBP <160, DBP<100)
Stage II-IV HTN
(SBP ≥160, DBP≥100)
Total Cholesterol, mg/dL

HDL-Ca, mg/dL

Diabetes
Current Smoking

Abbreviations: CI, confidence interval; DBP, diastolic blood
pressure; HDL-C, high density lipoprotein- cholesterol; HR, hazard
ratio; SBP, systolic blood pressure
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Table 5.3. Model Building to assess the association between Framingham Risk Score (FRS) assessment, cardiorespiratory fitness
(CRF), and coronary heart disease (CHD)
Model I,
Univariate model
Model II*
Model III†
Model IV±
Model V§
RISK FACTOR

HR
1.36

95% CI

HR

1.29

1.39

HR
1.36

95% CI
1.32

HR

95% CI

HR

95% CI

1.32

1.40

--

--

1.00

--

--

1.00

--

--

4.25

7.55

3.50

2.59

4.73

5.38

4.03

7.19

0.77

0.83

0.82

0.79

0.85

--

--

1.00

--

--

1.00

--

--

Moderate 0.93

0.71

1.22

1.15

0.88

1.52

0.98

0.75

1.30

High 0.67

0.51

0.88

1.11

0.84

1.47

0.74

0.56

0.98

FRS, points

1.34

95% CI

1.41

10 year CHD risk||
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1.00
Low Risk
‘Moderate or
5.66
High’ Risk
Maximally
0.80
achieved METs
Cardiorespiratory
Fitness
Low 1.00

0.95

0.91

1.00

Abbreviations: CI, confidence interval; CHD, coronary heart disease; HR, hazard ratio
*
Model II investigates the association between maximal METs achieved and CHD events while controlling for FRS point
summation and baseline examination year
†
Model III investigates the association between CRF categorized in to low, moderate, and high fitness and CHD events
while controlling for summation of FRS points and baseline examination year
±
Model IV investigates the association between maximally achieved METs and CHD events while controlling for
‘moderate or high’ 10 year CHD risk and baseline examination year
§
Model V investigates the association between CRF categorized in to low, moderate, and high fitness and CHD events
while controlling for ‘moderate or high’ 10 year CHD risk and baseline examination year
||
Low and ‘‘moderate or high’’ 10 year CHD risk is a comparative risk calculated from the summation of FRS points.
‘moderate or high’ risk is defined as a sum > 5 points.
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Figure 5.1. Study flow and Aerobic Center Longitudinal Study
(ACLS) inclusion criteria depicting final sample size and
coronary heart disease (CHD) event frequency
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Figure 5.2. Adjusted Hazard Ratios and 95% confidence intervals (95% CI) for the
relationship between cardiorespiratory fitness (CRF) and 10-year coronary heart disease
(CHD) risk stratified by ‘low’ and ‘moderate or high’ risk. A significant inverse
association is present among men with ‘low’ 10-year risk for CHD.
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CHAPTER VI
Addition of Estimated Cardiorespiratory Fitness to the Clinical Assessment of 10Year Coronary Heart Disease Risk in Asymptomatic Men1

1

Gander J, Sui X, Hébert JR, Hazlett LJ, Cai B, Lavie CJ, Blair SN. To be submitted to
Journal of the American College of Cardiology.
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Abstract
The Framingham Risk Score (FRS) was developed to quantify a patient’s CHD
risk; although, many clinicians recognize its limitations. Cardiorespiratory fitness’ (CRF)
is protective of CHD events, however the measurement is often not clinically viable.
Non-exercise estimated CRF (e-CRF) is a practical alternative that was computed and
tested in relation to the FRS and CHD.
Methods
Male participants (n=29,854) enrolled in the Aerobics Center Longitudinal Study
(ACLS), completed a baseline examination between 1979-2002, and were followed for
12 years to determine incident CHD defined either by self-report of myocardial infarction
or revascularization, or CHD mortality. Estimated CRF was defined from a 6-item
questionnaire and categorized using age-specific tertiles (low, middle, and high).
Multivariable survival analysis determined the crude and adjusted association between
FRS, e-CRF, and CHD. Interaction between e-CRF and FRS was tested by survival
analysis on a population stratified by ‘low’ and ‘moderate or high’ 10-year CHD risk.
Results
Compared to men with low e-CRF, men with high e-CRF group was significantly
(p-value < 0.0001) younger, had a higher proportion of optimal blood pressure, had a
lower proportion of total cholesterol ≥ 240 mg/dL, and were less likely to be smokers.
Unadjusted Cox analysis showed men with high e-CRF had a 36% (HR=0.64; 95% CI
0.51, 0.80) CHD risk reduction compared to the men with low e-CRF (p-value for trend
<0.001). In men with ‘low’ 10-year FHS predicted CHD risk, men with high e-CRF were
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28% (HR=0.72; 95% CI 0.0.57, 0.91) less likely to experience an incident CHD event
compared to men with low e-CRF.
Discussion
Among men with ‘low’ risk for CHD, those who were more fit had a decreased
risk for CHD compared to men in the lowest third of fitness. Estimated CRF can add
clinical value to the FRS and help clinicians predict long-tern CHD risk.

Introduction
Despite the decrease in coronary heart disease (CHD) incidence worldwide in the
past 30 years, 7,8 a decrease in age-adjusted CHD mortality in the United States (US), 184
and decrease in self-reported CHD 185 from 2006-2010, CHD remains one of the leading
causes of death in the U.S. 186 CHD risk factors include diabetes, 16 hypercholesterolemia,
14

hypertension, 74 and smoking. 11 Risk scores have been developed to enable clinicians

to quantify risk factors from their patients’ medical histories in order to provide an
estimate of CHD risk. 18,21,113

Sposito et al 24 reports from a cross-sectional survey among physicians that those
utilizing CHD risk scores primarily chose to use the Framingham Risk Score (FRS) 23.
The FRS was developed from the Framingham Heart Study (FHS) 23 and a 1998 version
by Wilson et al 113 categorized the aforementioned risk factors to determine 10-year CHD
risk and provide a score sheet for clinical implementation. The FRS’ predictive power has
persisted through validation in various populations 26,27 as well as modifications such as
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the inclusion of apolipoproteins, 106 C-reactive protein, 29 and involuntary job loss. 30
Despite FRS’ strengths and predictive power, clinicians from Sposito et al’s analysis
reported that the FRS was time-consuming and “does not add value to the clinical
examination.” 24

Similar to the FRS, cardiorespiratory fitness (CRF)’ protective effect on CHD 45,46
and other adverse events has been well documented. 34,43,88,127,141 In a study with more
than 22,000 men, a significant interaction between body composition and CRF reported
that unfit lean men had a significantly three times higher risk for CHD mortality
compared to fit lean men; unfit men with normal body composition had a 2.94 (95% CI
1.48, 5.83) times higher risk compared to fit lean men. 46 CRF has traditionally been
determined by an individual’s sex- and age-specific maximal oxygen uptake that is
ascertained through a maximal exercise test. Due to the methodologic rigor and
associated high costs, CRF has not been easily captured in clinical settings.

Recently, a 6-item, non-exercise, scale estimating CRF (e-CRF) 171 was recently
developed and incorporates age, body mass index (BMI), waist circumference, resting
heart rate, smoking status, and physical activity. Physical activity was captured through a
medical history questionnaire where participants reported their regular physical activity
for the past 3 months. 41,172 Physical activity was then dichotomized in to two levels: none
or low, and moderate or high physical activity. The accuracy of the developed algorithm
was determine by computing the random intercept’s square root of the sum and the
residual variances. 171,173 Since the scale to calculate e-CRF was developed, no study has
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investigated the association between e-CRF and CHD independently or in addition to a
CHD risk score such as the FRS. This study was designed to expand on previous
literature by determining the relationship between e-CRF and CHD. A second aim was to
evaluate the potential for the e-CRF to add clinical value to the FRS by testing for
improvement in predicting 10-year CHD risk.

Methods
Study Population
This study focused on men from the ACLS prospective cohort. The ACLS
participants were recruited from patients attending the Cooper Clinic in Dallas, TX for a
preventive medical examination and health behavior counseling. The participants
completed a baseline examination at the Cooper Clinic from 1979-2002. Men were
included in the analyses if they were between the ages of 30-74 years, had a BMI ≥18.5
kg/m2, were free of a previous CHD, cancer, or stroke diagnosis at baseline, reached a ≥
85% age-predicted maximal exercise heart rate at each visit, and had complete data with
a minimum of one year of follow-up. Figure 1 displays the inclusion and exclusion
criteria for this study.

Clinical Examination
Standardized protocols were followed by trained technicians at every clinical
exam. Personal and family medical history was taken during the baseline examination.
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Other clinical baseline measures included a 12-hour fasting cholesterol and glucose
measurement, blood pressure assessment, electrocardiogram, anthropometric
measurements, and a maximal exercise test. 112,164,166 A standardized questionnaire was
used to capture an individual’s current smoking status and medical history.

Measures
Definition of Outcome
CHD was defined either by self-reported myocardial infarction (MI), bypass,
coronary balloon, angioplasty, or stent placement, or by CHD mortality. Self-reported
history of CHD was collected through a mail-back survey administered in 1982, 1986,
1990, 1995, 1999, and 2004. CHD specific mortality was determined through linking the
ACLS cohort with the National Center for Health Statistic’s National Death Index. The
primary cause of death was determined by International Classification of Disease Ninth
(ICD-9) and Tenth (ICD-10) revisions. CHD mortality was classified with ICD-9 codes
410.0-414.0 and ICD-10 codes I20-I25. In accordance with FRS’s follow-up definition,
the cut-off for maximum follow-up time for CHD event was 12 years.

Primary Exposure
Estimated CRF (e-CRF) was expressed in metabolic equivalent of task (MET)
units. METs were estimated using a 6-item questionnaire. 170,174 The sex-specific
questionnaire is composed of a participant’s age, BMI, waist circumference (WC), resting
heart rate (RHR), two-level physical activity (activity), and smoking status (smoke).
These variables are applied to Jackson et al’s algorithm 171 below.
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The estimated METs were categorized into three age-adjusted e-CRF tertiles: low,
middle, or high e-CRF. This classification is similar to previous e-CRF studies 171.

Application of Framingham Risk Score
A composite 10-year CHD risk score was generated for each participant using the
FRS. The FRS was derived from the Framingham Heart Study and the 1998 modeling 113
to predict 10-year CHD risk. The FRS is a sex-specific and age-adjusted risk score that
incorporates categorical variables for blood pressure, total cholesterol, high density
lipoprotein cholesterol (HDL-C), diabetes diagnosis, and smoking status. Point values
were tabulated for each participant based on Wilson et al’s study 113 and the cohort was
stratified based on their ‘low’ or ‘moderate or high’ 10-year FHS predicted CHD risk. A
point summation > 5 points was considered ‘moderate or high’ risk of FHS predicted
CHD.

Statistical Analysis
Descriptive statistics were calculated for the total study population and stratified
by e-CRF. Chi-square tests and Cochran Armitage trend tests were conducted to
determine significant differences between the e-CRF levels and each risk factor. Death
rate per 10,000 person-years for follow-up was calculated for e-CRF and 10-year FHS
predicted CHD Risk. Crude Cox Proportional Hazard Models, adjusting for baseline
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examination year, were generated to determine the association between e-CRF and CHD,
and the relationship between 10-year FHS predicted CHD risk and actual CHD events. A
fully adjusted Cox Proportional Hazard Model was used to determine the relationship
between e-CRF, 10-year FHS predicted CHD risk and CHD. The effect of e-CRF on
CHD also was investigated on population subsets defined by age, smoking status,
hypertension status, and diabetes diagnosis. To investigate if there was a significant
interaction between e-CRF and 10-year FHS predicted CHD risk, the male ACLS
participants were stratified by ‘low’ or ‘moderate or high’ FHS predicted CHD risk and
hazard ratios between e-CRF and CHD were calculated. The receiver operating
characteristic (ROC) curves were plotted to determine if there was a significant
improvement in the predictive accuracy of CHD by augmenting the FRS point
summation with e-CRF. The chi-square test determined if there was a significant
difference between the models. The Hosmer-Lemeshow statistics was used to asses
calibration and goodness of fit; the statistics compares the predictive and observed events
but is limited to sample sizes smaller than 10,000 observations. 169 To control for this
limitation, a random sample population was generated from the larger study population to
perform this goodness of fit test. SAS® version 9.3 was used to perform all descriptive,
survival, and predictive analyses.

Results
There were 499 CHD events among 29,854 men (contributing 248,890 personyears of observation) (Figure 6.1). Table 1 displays the comparisons between men
stratified by their e-CRF. Men with low e-CRF had a higher proportion of CHD events

122

compared to high fit men. Men with low e-CRF were also less likely to have optimal or
normal blood pressure compared to men with moderate or high e-CRF. High-fit men
were more likely to have increased levels of HDL-C ≥60 mg/dL, be nondiabetic, and be a
nonsmoker compared to moderate or low-fit men.

Crude survival analysis, adjusted for baseline examination year, reported that both
e-CRF and ‘moderate or high’ 10-year FHS predicted CHD risk were statistically
significant with CHD (Table 6,2). In the crude Cox analysis, men with high e-CRF had a
36% (HR=0.64; 95% CI 0.51, 0.80) lower CHD risk compared to low fit men (p-value
for trend <0.001). This significant association between e-CRF and CHD remained in a
subsequent model controlling for ‘moderate or high’ 10-year FHS predicted CHD risk,
although effect size was slightly attenuated. The significant protective effect between eCRF and CHD was also found in subpopulations of male ACLS cohort members. Figure
2 reports that among men age ≥ 60 years, high fitness reduced CHD risk by 44%
(HR=0.56; 95% CI 0.32, 0.97). Among non-smokers, men within the highest fitness
tertile (HR=0.62; 95% CI 0.48, 0.79) had a smaller probability of a CHD event compared
to non-smokers with low e-CRF. Although similar protective effects were present for the
different classifications of hypertension, high e-CRF proved to be significantly protective
against CHD in men with optimal blood pressure.

Figure 6.3 portrays the association between e-CRF and CHD stratified by ‘low’
and ‘moderate or high’ FHS predicted CHD risk. Men with ‘low’ 10-year FHS predicted
CHD risk and high e-CRF have a 28% (HR=0.72; 95% CI 0.57, 0.91) lower risk of CHD
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compared to men with low 10-year FHS predicted CHD risk and low e-CRF. In men with
‘moderate or high’ 10-year FHS predicted CHD risk, men with middle e-CRF were 38%
(HR=0.62; 95% CI 0.32, 1.22) less likely to experience a CHD incident event compared
to men with low e-CRF. High e-CRF also was associated with a protective effect
(HR=0.69; 95% CI 0.31, 1.51) of CHD in men with ‘moderate or high’ FHS predicted
CHD risk, although neither relationship was not statistically significant.

The receiver operating characteristic (ROC) curves were plotted for ‘FRS point
summation only’ model and the ‘FRS point summation with e-CRF’ (Figure 6.4). The
Area Under the Curve was higher for the ‘FRS point summation with e-CRF’ (cstatistic=0.7987; 95% CI 0.7813, 0.8161) compared to the model ‘FRS point summation
only’ (c-statistic=0.7972; 95% CI 0.7798, 0.8146). The predictive power of these models
was not significantly different (p-value=0.90) but the goodness of fit test reported that the
predicted events were not different from the observed events with a Hosmer-Lemeshow
p-value>0.05.

Discussion
Men with middle or high e-CRF were at a significantly lower risk for CHD
compared to men with low e-CRF. Among men with ‘low’ FHS predicted risk for CHD,
high fit men had a significantly lower risk for CHD compared to men with low fitness.
To our knowledge, this is the first study to examine the relationship between e-CRF and
CHD and the protective effect of e-CRF on CHD among men with ‘moderate or high’
risk for CHD by the FRS assessment.
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The FRS has been validated in various populations with similar results to ours.
Male physicians in the US, enrolled in the Physician’s Health Study, reported their
coronary risk factors through a questionnaire at enrollment and completed follow-up
surveys every 6 months to capture CHD incidence. 27 The study found similar risk factors
associated with CHD as those reported in the Framingham Heart Study, with the
exception of smoking status. Additionally, D’Agostino et al conducted a comparison
analysis to determine the level of agreement between the FRS applied to the Framingham
Heart Study cohort and the FRS applied to non-Framingham Heart Study populations.
They concluded that the level of agreement was reasonably sound between the predicted
and actual CHD events, with the exception of the study implemented using the JapaneseAmerican cohort. 28

For the purposes of our study, ‘moderate or high’ CHD risk was defined through
the 1998 FRS that quantified categorically-defined risk factors in to a composite score. 113
The age-adjusted composite score included CHD risk factors of hypertension,
hypercholesterolemia, diabetes diagnosis, and smoking status. Many researchers report
that the decrease in CHD-related mortality and CHD incidence could be attributed to the
modification of these risk factors through prevention and close monitoring,
improvements of modifiable lifestyle characteristics, 9,10 and pharmacologic treatment of
risk factors out of acceptable ranges. 8

125

Similar to the FRS, which was comprised by several risk factors, CRF also is a
significant predictor of CHD and a modifiable risk factor. The Lipid Research Clinics
Prevalence Survey 45 divided approximately 4,000 men in to a healthy and unhealthy
group. Their investigation found that healthy men with high CRF had a lower risk for
CHD mortality compared to men with low CRF; unhealthy men with a history of CVD
and low CRF were 5.6 times more likely to die from CHD compared to men with a
history of CVD and high CRF. 45 CRF’s protective effect on CHD can be explained
through moderate and high fit individual’s having increased muscle mass 152, enhanced
arterial oxygen content, 152,153 improved glycemic control, 66 increased double-product
threshold for ischemic ST-segment depression, 154,155 and may protect against thrombosis
187

Several studies have reported on the modifiable qualities of CRF in various

populations. 47,188-190 Oja et al’s reported the significant improvement of heart rate
recovery and maximal oxygen uptake (traditionally used to determine CRF) 47 after an
18-month, exercise training program. A meta-analysis reported similar findings to Oja et
al’s and concluded that exercises, varying in duration and intensity, also improved CRF
with an average VO2max increase of 11.8%. 137

The current study expands on previous literature by investigating the protective
effects of e-CRF on CHD. Estimated CRF offers the predictive capability of traditionally
measured CRF 170 while reducing the cost/burden to the patient and clinician. As stated
above, improvements in fitness as estimated by e-CRF may lead to additional
improvements in other CHD risk factors such as hypertension and glycemic control and
should be considered as part of primary and secondary prevention.
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The limitations of this study should be noted and considered when determining
generalizability. Due to the small number of CHD events occurring in women, only men
were included in the present analysis. Future research should investigate the association
between e-CRF and CHD in asymptomatic women. The non-significant association
between e-CRF and CHD among stage II-IV hypertensive men may be due to the small
proportions and generalizations toward this group should also be made cautiously. It also
should be noted that the ACLS cohort consists predominately of non-Hispanic White
individuals from middle to upper socioeconomic status who were relatively young (i.e.,
with a mean age of 42 years). Although this limitation may be considered a strength
because of its tendency to improve internal validity while exerting inherent control for
possible demographic confounders, generalizations and implementations of e-CRF
should be made cautiously.

Conclusion
Our study found that among men with ‘low’ risk for CHD by the FRS, those with
high fitness had a lower risk for CHD when compared to men with low fitness. Increasing
awareness through early quantification of a patient’s risk for CHD is important for CHD
prevention. Although the FRS is a validated tool that enables physicians to assess an
individual’s risk, many clinicians have questioned the ability of the FRS to add to the
standard overall clinical evaluation. Our results suggest that an assessment of e-CRF may
add considerably to the clinicians’ overall risk assessment for CHD. The results of this 6item survey (age, waist circumference, BMI, physical activity, resting heart rate, and
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smoking status) which can be quickly and easily collected during a clinical exam by
paramedical staff, can help clinicians predict adverse CHD events and provide
ammunition for the promotion of physical activity and exercise training for improving
CRF and CHD risk. 182,183
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Table 6.1. Demographics of participants stratified by estimated cardiorespiratory fitness

182 (1.83)

30-74
44.7

Low
e-CRF
174
(1.75)
30-74
49.7

30-74
46.8

High
e-CRF
143
(1.44)
30-70
42.1

2.1

3.7

1.7

0.8

<0.001

28.8

16.6

29.4

40.4

<0.001

31.8

29.2

33.7

32.6

<0.001

16.0

18.6

16.1

13.2

<0.001

18.7

26.9

17.4

11.9

<0.001

4.7

8.7

3.4

1.9

<0.001

9.2

6.8

8.2

12.5

<0.001

160-169

34.1

28.7

33.3

40.3

<0.001

200-239

36.9

38.5

37.9

34.3

<0.001

240-279

15.3

19.6

15.7

10.6

<0.001

≥280

4.5

6.4

4.8

2.3

<0.001

<35
35-44
45-49
50-59
≥60

15.6
34.1
15.6
21.4
13.3

24.8
39.9
13.8
15.1
6.5

14.2
36.0
16.7
21.4
11.7

7.9
26.5
16.2
27.7
21.7

<0.001
<0.001
<0.001
<0.001
<0.001

RISK FACTOR
Number of CHD
Events (%)
Age, range (years)
Mean Age, y
Moderate or High 10year CHD risk
Blood Pressure, mm
HG
Optimal
(SBP<120, DBP<80)
Normal
(SBP <130, D<85)
High Normal
(SBP <140, DBP<90)
Stage I HTN
(SBP <160, DBP<100)
Stage II-IV HTN
(SBP ≥160, DBP≥100)
Total Cholesterol,
mg/dL
<160

Total
Population
499 (1.67)

Moderate
e-CRF

CochranArmitage
Trend
p-value

0.08
<0.001

HDL-C, mg/dL
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Diabetes
1.4
2.8
0.9
0.6
<0.001
Current Smoker
16.6
24.4
17.1
8.1
<0.001
Abbreviations: DBP, diastolic blood pressure; e-CRF, estimated cardiorespiratory
fitness; HDL-C, high density lipoprotein- cholesterol; SBP, systolic blood pressure
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Table 6.2. Adjusted survival risks for coronary heart disease (CHD) events by estimated
cardiorespiratory fitness (e-CRF) or 10-year CHD risk group
Number
Death
HR
HR
N
of
†
Rate*
(95% CI)
(95% CI)‡
Deaths
Estimated CRF
(e-CRF)
Low 5970
152
31.93
1
1
0.93
(0.76, 1.14)

0.99
(0.81, 1.22)

0.64
(0.51, 0.80)
<0.001

0.71
(0.56, 0.88)
0.003

18.34

1

1

102.58

5.59
(4.20, 7.45)

5.25
(3.92, 7.01)

Moderate 11942

211

18.90

High 11942

136

10.31

P value for trend
10-year CHD Risk
Low 29241

447
52

Moderate or High

613

Abbreviations: CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio
*Deaths per 10,000 person-years of follow-up adjusted for examination year
†
‡

Adjusted for examination year
Further adjusted e-CRF for 10-year CHD risk or 10-year CHD risk for e-CRF
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Figure 6.1. Inclusion criteria for the study population from the
Aerobic Center Longitudinal Study (ACLS) inclusion criteria
depicting final sample size and coronary heart disease (CHD)
event frequency. Men with complete Framingham Risk Score
(FRS) data, estimated cardiorespiratory fitness (e-CRF) data,
and body mass index (BMI) ≥ 18.5 kg/m2 were included in the
analysis.
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1.2

1.2

1

1

Hazard Ratio

Hazard Ratio

1.4

0.8
0.6
0.4

0.6
0.4
0.2

0.2

0

0

Age<60

Age

Non-Smoker

Age 60
Age≥60

Smoker

Smoking Status

1.6

3.5

1.4

3

1.2
Hazard Ratio

Hazard Ratio

0.8

1
0.8
0.6
0.4
0.2

2.5
2
1.5
1
0.5

0
Optimal

Normal

High
Normal

Stage I StageII-IV
HTN
HTN

Hypertension (HTN)

0

No

Yes

Diabetes Diagnosis

Figure 6.2. Multivariable adjusted hazard ratio and 95% confidence intervals for
estimated cardiorespiratory fitness (e-CRF) and coronary heart disease (CHD) events
among population subsets. Survival models are adjusted for baseline examination year.
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2
1.82

1.8
1.6

Estimated
CRF
Low
Moderate
High

Hazard Ratio

1.4

1.2
1.02

1

0.89

0.8
0.6

0.55
0.56

0.4
0.30

0.2
0

1.00

0.76

0.28

0.41

1.00

Low

0.50

0.22

0.62

Moderate or High
10-year CHD risk

Figure 6.3. Adjusted survival analysis to determine the association between estimated
cardiorespiratory fitness (e-CRF) and risk of CHD. Population was stratified by ‘low’ and
‘moderate or high’ 10-year Framingham Heart Study (FHS) predicted CHD risk to
display the interaction between 10-year CHD risk and CRF.
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Model
A. Framingham Risk Score
point summation
B. Framingham Risk Score
point summation and e-CRF

Area
Predicted and
ROC curve
Under 95% Confidence
Observed events
the Curve
p-value
Interval
difference p-value
0.7972

0.7798 0.8146

0.7987

0.7813 0.8161

0.9046

0.1313

Figure 6.4. Receiver Operating Characteristic Curve comparing the
predictive ability of the Framingham Risk Score (FRS) point summation
(Model A) compared to the Framingham Risk Score point summation and
estimated cardiorespiratory fitness (e-CRF) (Model B). Both models were
applied to the ACLS cohort with a 12 year follow-up. The HosmerLemeshow c-statistic is represent by the Area Under the Curve for Model
A(c=0.7972; 95% CI 0.7798, 0.8146) and B (c=0.7987 95% CI 0.7813,
0.8161) with no significant difference (p=0.9046). The chi-square test for
difference between predicted and observed events is not significantly
different (p=0.1313).

135

CHAPTER VII
SUMMARY

Coronary heart disease (CHD) incidence has decreased worldwide in the past 30 years. 7,8
Age-adjusted CHD mortality has decreased in the U.S., 184 and self-reported prevalence
in the U.S. has also decreased 185 from 2006-2010. Despite these statistics, CHD still
remains one of the leading causes of death in the U.S. 186 The Framingham Risk Score
(FRS) is an age-adjusted, sex-specific composite score that incorporates CHD risk factors
such as hypertension, hypercholesterolemia, diabetes diagnosis, and smoking status. The
FRS does not include cardiorespiratory fitness (CRF), a factor consistently shown to have
a protective effect on CHD 45,46 and other adverse outcomes. 34,43,88,127,141
The purpose of this research was to validate the FRS in the Aerobics Center
Longitudinal Study (ACLS) cohort; update and improve the predictability of the FRS
through the addition of CRF while resolving limitations in previous studies; and assess
the predictability of non-exercise estimated CRF (e-CRF) and FRS on CHD.
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PAPER 1: Framingham Risk Score applied to the Aerobic Center Longitudinal
Study (ACLS)
Risk factor scores, have been developed to help clinicians quantify their patient’s
CHD risk, 18,23,113 and the FRS is the most commonly used. 24 Although the FRS has been
validated in various populations, 6,26,175 most lacked congruency with FRS methodology
or had small sample sizes. This paper aimed to improve upon recent literature by strictly
applying the FRS to the large ACLS cohort. We hypothesized that the FRS would be
significantly predictive of CHD events for men within the ACLS population.

Data collected from men (n=34,557) in the ACLS cohort were used to complete
the multivariable survival analysis and determine the relationship between FRS variables
and 10-year CHD risk. The FRS variables included age, systolic and diastolic blood
pressure, total cholesterol, high density lipoprotein cholesterol (HDL-C), diabetes
diagnosis, and smoking status. The analysis found that the FRS variables applied to the
ACLS cohort had similar results compared to the original publication, 113 with a
predictive statistic of 0.77 (95% CI 0.75, 0.79). This study further validates the FRS
predictive ability of 10-year CHD risk although limitations still exist. To control for
potential limitations, future research should focus on the expansion of the FRS to include
other modifiable risk factors, such as CRF.
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PAPER 2: Augment the Framingham Risk Score (FRS) applied to the Aerobic
Center Longitudinal Study (ACLS) with the addition of Cardiorespiratory Fitness
(CRF)
The FRS provides a sex-specific, age-adjusted risk score that accounts for systolic
and diastolic blood pressure, total cholesterol, high density lipoprotein cholesterol,
diabetes diagnosis, and smoking status. 25 Previous studies 29,30,104 have modified the FRS
to include additional risk factors. None of these modifications involved the addition of
cardiorespiratory fitness (CRF), a characteristic that has shown significant protective
effects for all-cause mortality, 43,136 cancer-related mortality, 139 diabetes incidence, 34
CHD incidence 47 and mortality. 25,45,46 In this paper, we aimed to expand on previous
literature by modifying FRS with CRF and hypothesized that CRF would improve the
FRS predictive ability of CHD events for men within the ACLS population.

The ACLS cohort was utilized for this analysis and included men who completed
a baseline examination between 1970 and 2003 (n=29,854). FRS was applied as a
composite score to each participant and a binomial (‘low’ and ‘moderate or high’) 10year CHD risk was determined. Multivariable Cox Regression analysis was used to
determine the relationship between CRF, FRS, and CHD. The population also was
stratified by ‘low’ and ‘moderate or high’ risk for CHD to test for interaction between
CRF and FRS. The study concluded that men within the ‘low’ 10-year CHD risk strata
and moderate (HR=0.92 95% CI 0.68, 1.25) or high (HR=0.62, 95% CI 0.45, 0.84) CRF
had a lower probability of experiencing CHD compared with men in the same strata with
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low CRF (p-value <0.001). CRF is a modifiable risk factor with a protective association
with CHD. It may be advantageous for clinicians to evaluate a patient’s CRF to provide a
more accurate assessment of the 10-year risk for CHD.

PAPER 3: Determine the association between non-exercise estimated CRF (e-CRF)
and CHD. Utilize e-CRF and FRS to predict the risk of CHD.
Determining a patient’s risk for CHD early is important to primary prevention.
The FRS was developed to assist physicians in completing this task. The FRS’ predictive
power has been consistent in various populations 26,27 and additions of various risk factors
29,30,106

but some physicians still believe the FRS does not provide additional clinical

value 24. CRF’s significant predictive effects on CHD have also been well documented,
however, until recently, CRF was not easily ascertained in a clinical setting 170. Our aim
for this study was to improve on the FRS and CRF limitations by analyzing non-exercise
estimated CRF (e-CRF) with FRS to predict 10-year CHD.
Men (n=29,854) in the ACLS cohort who completed a baseline examination at the
Cooper Clinic in Dallas, TX were included in the analysis. Crude and adjusted Cox
Proportional Hazard Ratios were calculated for the association between estimated CRF
(e-CRF), FRS, and CHD. The relationship between e-CRF and CHD was also analyzed in
subsets of the population based on age, smoking status, hypertension, and diabetes
diagnosis. To test for interaction between e-CRF and FRS, a survival analysis between eCRF and CHD was conducted on a population stratified by ‘low’ and ‘moderate or high’
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10-year CHD risk. Our main finding from these analyses was that among men with
‘moderate or high’ risk for CHD, men with moderate e-CRF were 50% (HR=0.50; 95%
CI 0.28, 0.89) less likely to experience a CHD incident compared to men with low eCRF. A secondary finding was that the significant protective effect e-CRF has on CHD
among population subsets. Among current smokers, men with moderate e-CRF
(HR=0.52; 95% CI 0.32, 0.84) or high CRF (HR=0.37; 95% CI 0.22, 0.65) had a smaller
probability of a CHD event compared to current smokers with low e-CRF. This study
provides additional clinical value to the FRS by augmenting the traditional risk score
with e-CRF.

OVERALL DISCUSSION AND FINDING
CHD is one of the leading causes of death in the U.S. and early establishment of
CHD risk is important for primary and secondary prevention. The FRS encompasses
some of CHD’s major risk factors, except CRF is not included. A recent study provided
researchers and clinicians with a tool to determine a patient’s non-exercise estimated
CRF through a 5-item scale. The series of papers presented in this dissertation provide
the evidence needed to establish a more comprehensive and clinically feasible CHD risk
prediction tool. This research concludes that the FRS was consistently predictive of 10year CHD events. FRS’s effect is improved through the addition of CRF to provide a
more clinically accurate prediction of individual 10-year CHD risk. Clinicians may want
to consider capturing their patients’ medical history, CHD risk factors, and their e-CRF
so they can take advantage of CRF’s improved prediction of CHD. This comprehensive
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approach can help physicians predict adverse events for their patients while also
counseling them on how to improve their overall health through improvement of CRF.

FUTURE DIRECTIONS AND RESEARCH
There are several research ideas that stem from the presented conclusions. To
further the presented results in each of the three papers, the analysis should be replicated
for females. FRS 104 and CRF 42,85 have both been shown to have significant associations
with CHD and other outcomes but the combined association with FRS and CRF should
be assessed with the CHD outcome in women. To improve the external validity of our
findings, the association between FRS, CRF, and CHD will need to be investigated in
women.
Future studies may want to replicate these FRS analyses using D’Agostino et al’s
176

2008 version, which focuses on cardiovascular disease (CVD) as an outcome which

encompasses CHD diagnosis, as well as stroke and coronary artery disease. Although
CHD comprises the majority of CVD diagnoses, utilizing a CVD risk score may provide
a prediction with broader implications but may be potentially less accurate.
Furthermore, e-CRF relationship with other adverse outcomes should be explored.
Since Jurca et al 170 published the non-exercise e-CRF scale, the scale has been validated
191

and applied to selective populations such as older adults 192. The measurement of e-

CRF may provide significant interpretations for both research and clinical settings. Future
clinical research should focus on capturing e-CRF to analyze effects on short and longterm outcomes. CRF’s ability to be modified through exercise 47,137 and CRF’s effect on
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CHD risk factors such as glycemic control an cholesterol make e-CRF a very useful
measure for the clinical setting.
CONCLUSION
This dissertation involved implementing sophisticated, predictive modeling to
determine the association between CRF, FRS, and CHD. The statistical analyses were
based on a subset of data from ACLS, a large cohort derived from the patients of the
Cooper Clinic in Dallas, TX. The information and interpretations gained from this
research provide further comprehension of FRS and CRF as well as suggestions for new
clinical protocols for physicians to consider. We stress the importance of a
comprehensive medical approach while balancing the burden placed on the physician and
patient. We believe that e-CRF is an accurate assessment tool for CHD independent of,
and jointly with FRS, and should be implemented in the clinical setting.
This dissertation process was a valuable experience that enhanced my
appreciation of academia and clinical research. My dissertation challenged me
academically to apply and interpret statistical methodology I had not previously learned.
The receiving operating characteristic (ROC) curve helps determine the predictability of
a model on the outcome of interest and was applied to each of the three manuscripts. I
had to go beyond the simple application of the ROC curve and determine if this analytical
method was appropriate for the data by examining the ROC curve’s strengths and
limitations. Fortunately, academia recognizes the necessity for collaboration to generate
and test research hypothesis. The collaboration characteristic of academia made learning
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a new statistical method easier because it enabled me to consult with other researchers
and gain their perspective on this method and the best approaches.
Collaborating can also save time and provide motivation to complete a project.
When I initiated my dissertation and began to formulate my scope and specific aims, I did
not fully appreciate the limiting ability of data or other student’s work-in-progress. After
review of the published literature and months developing potential aims, I drafted and
discussed a miniature proposal with my chair and co-chair. This collaboration helped me
refine my specific aims, determine the potential variables that were available for analysis,
and learn about the ongoing projects my peers were investigating in the ACLS cohort.
Without this collaboration, I might have spent a few more months developing hypotheses
that could not be investigated in ACLS or that another researcher was already developing.
Throughout my time spent obtaining my doctoral degree, I began my transition
from an epidemiology student to a career as a junior epidemiologist. Part of this transition
encompassed enhanced partnership with physicians and medical staff. My involvement
with clinical research has forced me to acknowledge limitations such as imperfect data
and limited sample size while capitalizing on the strength of the data. The enhanced
appreciation for clinical research while still working with a large, prospective cohort
provided me the opportunity to engage in the full spectrum of study designs. With
encouragement from my dissertation committee and my clinical research colleagues, I
have begun developing research projects to apply the knowledge and research experience
that I gained during my dissertation with ongoing or new clinical research ideas.
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This dissertation process has served as a hands-on learning experience that
enhanced my epidemiological and statistical knowledge, improved my analysis and
research skills, and enabled me to bridge my past research interests and experience with
new opportunities. I hope to continue my work with both the University of South
Carolina and my clinical research team to help integrate estimated cardiorespiratory
fitness in a clinical setting and show clinicians the value of this metric.
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